medical oncology, esmo fund guides for patients...bladder cancer: a guide for patients - information...
TRANSCRIPT
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 1
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
èè±çïŒæ£è ããã®æåŒã
ESMO蚺çã¬ã€ãã©ã€ã³ã«åºã¥ããæ£è ããåãæ å ±
æ¥æ¬èªèš³ççºè¡ã«ããã
ããæ£è ããã®æãåå®ãªèŠæã®äžã€ãããèªèº«ã®çœ¹æ£ããããã«é¢ããæ£ç¢ºãªæ²»çæ å ±ãåŸ
ãããšã§ããæ¥æ¬çæ²»çåŠäŒã§ã¯åçš®åŠè¡å£äœãçºåããããé¢é£èšºçã¬ã€ãã©ã€ã³ã®å ¬éãã
ãæ²»çå šè¬ã«é¢ãã暪æçããæ²»çæ¯æçæ³ã«é¢ãã蚺çã¬ã€ãã©ã€ã³ã®çå®ãªã©ãè¡ã£ãŠåã
ãŸãããäžéšã®ããã§ã¯æ£è ããããã®ã家æã«ãããããããäžè¬åããã®èšºçã¬ã€ãã©ã€ã³
ãçºåãããŠããŸãããããããç¶²çŸ ããé åã¯ãŸã ååãšã¯èšããªãç¶æ³ã§ãã
ããæ£è ããã«ãšã£ãŠæã倧åãªæšæºæ²»çã«ã€ããŠåããæã解説ããã¬ã€ãã©ã€ã³ãæäŸã
ãç®çã§ãæ¬åŠäŒåçäºé·ã®è¥¿å±±æ£åœŠå çãšåœæã®æ¬§å·èšåºè «çåŠäŒïŒEuropean Society of
Medical Oncology, ESMOïŒäŒé· Rolf A. Stahel å çãåæãããESMO/Anticancer
Fund Guides for Patients æ¥æ¬èªèš³ããçºåããããšãšãªããŸãããæ¥æ¬ãšæ¬§å·ã§ã¯äœ¿çšå¯èœ
ãªæè «çè¬ãæè¡æ¹æ³ãªã©ãè¥å¹²ç°ãªããŸãããç æ ã®ç解ãæ²»çã®æµããªã©æ£è ããã«ããã
ããã解説ããã蚺çã¬ã€ãã©ã€ã³ã¯å€§å€è²Žéãªæ å ±æºãšãªãããšãæåŸ ãããŸãããŸããæ¬éŠ
ã«ãããŠããããæ£è ããåãã®èšºçã¬ã€ãã©ã€ã³ãçºåããåŸæŒããšããªããæ£è ããåãã¬
ã€ãã©ã€ã³ã®ããæ¹ã«ã€ããŠã倧å€åèã«ãªããã®ãšæåŸ ããŠãããŸããæ¬ã·ãªãŒãºã®ç¿»èš³ãäœ
æã«å€å€§ãªããå°œåãé ããæ¥æ¬çæ²»çåŠäŒçäºãæè²å§å¡äŒãç·šéå§å¡äŒã®çæ§ãã¯ãããã
æ¯æŽãäžãã£ããã¹ãŠã®çæ§ã«å¿ããæè¬ç³ãäžããŸãã
å¹³æ 28幎 7æ æ¥æ¬çæ²»çåŠäŒ
çäºé· åå·éå
ãã®åºŠãESMO ïŒæ¬§å·èšåºè «çåŠäŒïŒã®çºè¡ããâESMO Guides for Patientsâã
ãESMO æ£è ããã®æåŒãããšããŠæ¥æ¬èªèš³ããæ¥æ¬ã®çæ£è ããã«æäŸããããšã«ãªããŸã
ãã
æè¿ã®çæ²»çã®çºå±ã¯ãããŸãããçæ£è ããã«ãšã£ãŠã¯æ°å€ãã®æ²»çæ³ã®éžæãå¯èœã«ãªã£
ãŠããŠããŸããæ£è ããã«ãšã£ãŠã¯æå ±ã§ãããããããã£ãœãã§ã¯å€§éã«çºä¿¡ãããæ å ±ã®äž
ã§ãçã«æºããå»çåŸäºè ãšæ£è ãããšã®éã§ã®ç¥èã®ã®ã£ãããåé¡ã«ãªã£ãŠããŸããããµã
ãããæ å ±ã®äžã§ãçã«å¯Ÿããæ£ç¢ºãªæ å ±ãæŽçããèªåã«æé©ãªæ²»çæ³ãèŠã€ãåºãããšã¯æ¬
åœã«é£ããããšã§ããããšæããŸãããã®ãããªæ å ±ã®æµ·ã®äžã§è¿·ã£ãŠããçæ£è ããã«å¯Ÿãã
ã¬ã€ã圹ãšããŠããã®ãESMOæ£è ããã®æåŒããã¯äœæãããŠããŸãã
ãã®æåŒãã¯âESMO/Anticancer Fund Guides for Patientsâ ããåºæ¥ãã ãå¿ å®ã«æ¥
æ¬èªèš³ããããšã«ããŠãããŸãããšãŒããããšæ¥æ¬ã§ã¯ãä¿éºå¶åºŠãå«ãå»çäºæ ãè¥å¹²ç°ãªã£
ãŠããŸãã®ã§ããã®æåŒãããã®ãŸãŸæ¥æ¬ã®æ£è ããã«åœãŠã¯ãŸããªãããšãããããšæããŸãã
ããå€æã«å°ãããšããããŸãããã䞻治å»ã®å çã«çŽæ¥ãèãããã ããã°ãšæããŸãã
ãã®æåŒããæ¥æ¬ã®çæ£è ããã«ãšã£ãŠæçšãªæ¡å 圹ãšãªãããšãæåŸ ããŠããŸãã
æåŸã«ããã®æåŒãã®äœæã«å°œåããã ããæ¥æ¬çæ²»çåŠäŒæè²å§å¡äŒããããŠç·šéå§å¡äŒã®å
çæ¹ã«å¿ããæè¬ããããšæããŸãã
å¹³æ 28幎 7æ æ¥æ¬çæ²»çåŠäŒ
ç·šéå§å¡äŒå§å¡é· å°å·ä¿®
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 2
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
èè±çïŒæ£è ããã®æåŒã
ESMO 蚺çã¬ã€ãã©ã€ã³ã«åºã¥ããæ£è ããåãæ å ±
翻蚳 æ ¶æ矩塟倧åŠå»åŠéšæ³å°¿åšç§ïŒ
æŸæ¬äžå®ãèå°æ 次ãè»ååºäžéãæ¬é·åšã倧家åºå£
ãã®æ£è ããçšæåŒãã¯ãæ£è ãããšã家æããèè±çãã©ã®ãããªç æ°ã§ãããããã
ç解ããèè±çã®ç¶æ ã«å¿ããæåã®æ²»çãåããããšãã§ããããã«ãããå æåºé
(Anticancer FundïŒã«ããæºåããããã®ã§ããæ£è ããã«ã¯ããèªèº«ã®èè±çã®ç ç¶ã
ç æã«ãã£ãŠãã©ã®ãããªæ€æ»ãæ²»çãå¿ èŠã§ããããæ åœå»ã«èããŠããã ãããšããå§
ãããŸããããã«æ²èŒãããŠããå»åŠçãªæ å ±ã¯æ¬§å·èšåºè «çåŠäŒ(European Society for
Medical Oncology: ESMO)ã®èè±çã®ããã®èšºçã¬ã€ãã©ã€ã³ã«åºã¥ãããã®ã§ãããã®
æ£è ããçšæåŒã㯠ESMO ã®ååã®ããšã§äœæãããESMO ã®èš±å¯ã®ããšé åžãããŠããŸ
ãããã®æåŒãã¯å»åž«ã«ããå·çãããå°éå»åã蚺çã¬ã€ãã©ã€ã³ã®äž»èŠãªèè ãå«ãã
ESMO æå±ã®äºåã®è «çå»ã«ãã£ãŠç£ä¿®ãåããŠããŸãããŸããESMO ã®ããæ£è ã¯ãŒã
ã³ã°ã°ã«ãŒãã®ä»£è¡šè ã«ãç£ä¿®ãåããŠããŸãã
ããå æåºéïŒAnticancer FundïŒã«é¢ããæ å ±ãæŽã«ç¥ãããå Žåã¯ä»¥äžã®ãµã€ããžã¢
ã¯ã»ã¹ããŠäžããïŒ www.anticancerfund.org
欧å·èšåºè «çåŠäŒïŒESMOïŒã«ã€ããŠæŽã«ç¥ãããå Žåã¯ä»¥äžã®ãµã€ããžã¢ã¯ã»ã¹ããŠäžã
ãïŒ www.esmo.org
ïŒãä»ããçšèªã«é¢ããŠã¯ãå·»æ«ã«æ³šéããããŸãã
ãæ¥æ¬èªçã翻蚳ããæ¥æ¬çæ²»çåŠäŒãã泚èšã
ãã®æåŒãã¯æ¬§å·èšåºè «çåŠäŒïŒESMOïŒã«ãã 2016 幎ã«äœæããããã®ããESMO ãš
ã®å¥çŽã«åºã¥ããæ¥æ¬çæ²»çåŠäŒãåæã«å¿ å®ã«æ¥æ¬èªã«ç¿»èš³ãããã®ã§ãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 3
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
ç®æ¬¡
èè±çã«ã€ããŠã®ãŸãšã ............................................................................................................................................. 4
èè±çã®å®çŸ© ..................................................................................................................................................................... 6
èè±çã®é »åºŠã¯ïŒ ............................................................................................................................................................ 7
èè±çã®åå ã¯ïŒ ............................................................................................................................................................ 8
èè±çã®èšºæã¯ïŒ ........................................................................................................................................................ 10
é©åãªæ²»çãåããã«ã¯äœãéèŠãïŒ ............................................................................................................ 12
æ²»çã®éžæè¢ãšããŠäœãããã®ïŒ ...................................................................................................................... 15
æ²»çã®å¯äœçšã®å¯èœæ§ãšããŠäœãããã®ïŒ ................................................................................................... 19
æ²»çåŸã«ã©ããªããšãèµ·ãåŸããïŒ ................................................................................................................. 22
çšèªã®èª¬æ ...................................................................................................................................................................... 24
ãã®ããã¹ã㯠Dr. An Billiauã Celsus Medical Writing, LLC (Anticancer Fund)ã«ããå·çãããDr.
Svetlana Jezdic (ESMO)ã Pr. Joaquim Bellmunt (ESMO)ãPr. Louis Denis (Stoma-Ilco, Europa
Uomo ïŒ ESMO ããæ£è ã¯ãŒãã³ã°ã°ã«ãŒãã®ä»£ç)ã«ããç£ä¿®ãããŠããŸãã
ä»åãã¯ãããŠã®æ¹èšãšãªããŸããESMO 蚺çã¬ã€ãã©ã€ã³ã®éå»ã®æ¹èšçã®å€æŽç¹ãåæ ãããŠããŸããä»
åã®ååæ¹èšã¯ Dr. Ana Ugarte (ACF)ã«ãã£ãŠãªããã Dr. Svetlana Jezdic (ESMO)ãš Vanessa
Marchesi, PhD (ESMO)ã«ããç£ä¿®ãããŠããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 4
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
èè±çã«ã€ããŠã®ãŸãšã
èè±çã®å®çŸ©
èè±ã®çŽ°èããçºçããçã®ããšã§ãããã®æåŒãã§ã¯èè±ã®ç§»è¡äžç®ãšãã°ããå è ã®äž
ç®ããçºçããçã«ã€ããŠè¿°ã¹ãŸããä»ã®ã¿ã€ãã®èè±çãååšããŸããããã®æåŒãã§ã¯
è¿°ã¹ãŸããã
蚺æ
äžè¬çãªèè±çã®çç¶ã¯ãè¡å°¿ãæå°¿æçãå°¿ãåºã¥ãããªã©æå°¿ã®åé¡ã§ããããã
ãããçç¶ã¯èè±çã«ç¹ç°çãªãã®ã§ã¯ãªããç以å€ã®çŸæ£ã§ãèªããããŸããèè±ç
ãšç¢ºèªããããã«ã¯ãèè±ãå°¿éå ã®è «çã®æç¡ã調ã¹ãèè±é¡æ€æ»ãè¡ãããŸãã
èè±ç蚺æãé²è¡ã®çšåºŠã調ã¹ãæå©ããšãªãç¹æ®ãªæ€æ»ããããŸããããã確å®èšºæ
ã¯ãè «çããæ¡åããçµç¹ãçšããç ççµç¹åŠçæ€æ»ã§ããè¡ãããšãã§ããŸãããã
ãã«ããè «çã®ç¹åŸŽãèè±çã®ã¿ã€ãã決å®ããããšãã§ããŸãã
ç æïŒã¹ããŒãžïŒã«å¿ããæ²»ç
çå±€é浞最çïŒã¹ããŒãž 0aãã¹ããŒãž 0isãã¹ããŒãž IïŒã¯ç²èå ïŒèè±å è ã®è¡šå±€ïŒ
ã«ãšã©ãŸã£ãŠããè «çã®ããšã§ãã
o èè±é¡æ€æ»ã®ããšãè «çã¯çµå°¿éçèè±è «çåé€è¡ïŒTURBT)*ã«ãŠåé€ãããŸãã
è «çãå®å šã«åé€ããããšãã§ããã°ãæ²»çãæåŸ ã§ããŸãã
o ãšãã©ãåçºãé²å±äºé²ç®çã®è¡åŸè£å©çæ³*ãšããŠãèè±å æ³šå ¥ã«ããååŠçæ³ã
å ç«çæ³*ãè¡ãããŸãã
o ãããããæ²»çãå¹æã瀺ããªãã£ãå Žåã«ã¯ãèè±å šæãæ²»çéžæè¢ãšãªããŸãã
ç局浞最çïŒã¹ããŒãž IIãIIIïŒã¯èè±ã®çå±€ãŸã§æµžæœ€ããŠããããèè±åšå²ã®èèªçµç¹ã«
ãŸã§æµžæœ€ããŠããè «çã®ããšã§ãã
o æšå¥šãããæ²»çæ³ã¯èè±å šæãšåšå²ã®èåšã®å®å šãŸãã¯éšååé€ã§ãããããæè¡
ã¢ãããŒãã¯åšå²ã®èåšãå¯èœãªãããæž©åãããããå€æŽããããšããããŸãã
o è¡åã®ååŠçæ³ãŸãã¯æŸå°ç·çæ³ããæè¡æ瞟ãæ¹åãããããšãç¥ãããŠããæš
奚ãããŠããŸããããæ£è ãããæè¡ãåžæãããªãã£ãããæè¡ãå°é£ãªå Žåã«
ã¯ãæŸå°ç·åç¬ãaggressive TURBT*ãæŸå°ç·æ²»çãååŠçæ³ã䜵çšãã
TURBT*ãæ²»çéžæè¢ãšãªãããŸãã
é²è¡æ§ã»è»¢ç§»æ§èè±çïŒã¹ããŒãž IVïŒã¯ãè «çã骚ç€å£ãè ¹å£ãŸã§æµžæœ€ããŠããããé¢
ããèåšã«ãŸã§åºãã£ãŠããç¶æ ã§ãã
o ãã®ã¹ããŒãžã§ã¯æè¡ã§æ ¹æ²»ããããšãã§ããªããããååŠçæ³ãæšå¥šãããŸãã
äžéšã®æ£è ããã§ã¯ååŠçæ³åŸã®æè¡ãæŸå°ç·æ²»çã«ããæ²»çå¹æãããããšãã
ããŸãã
o æŸå°ç·æ²»çã¯çã¿ãåºè¡ã®ç·©åç®çã«çšããããšãã§ããŸãã
åçºãžã®æ²»ç:
o ãã³ãã«ãã³çæ³ãšæ¯æçæ³ãæšå¥šãããŸãã
o åçºäŸã§ã¯ãã¿ããµã³ç³»ããã©ããç³»æçå€ãããŒã¹ãšããååŠçæ³ãèæ ®ãããŸ
ãã
o æ²»éšãžã®åå ãªã©ãæšå¥šãããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 5
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
ãã©ããŒã¢ãã
èè±çã®ã¹ããŒãžãåçºãªã¹ã¯ã«å¿ããŠãæ€æ»ã¹ã±ãžã¥ãŒã«ãçµãŸããŸããçå±€é浞最çã®
å Žåãæåã® 2 幎㯠3ïŒ6 ã¶æããšã«ããã®åŸã¯ 6ïŒ12 ã¶æããšã«å蚺ãå¿ èŠã§ãïŒãã
ãå»åž«ã®æ瀺ã«åŸã£ãŠãã ããïŒã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 6
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
èè±çã®å®çŸ© æ¬å®çŸ©ã¯ã¢ã¡ãªã«åœç«ããç 究æïŒNCIïŒã®èš±å¯ãåŸãŠåŒçšããŠããŸãã
èè±çãšã¯èè±çµç¹å ã«åœ¢æãããçã®ããšã§ããèè±ã¯å°¿ã貯ããèåšã§ããæãé »åºŠã
é«ãã¿ã€ãã¯ã移è¡äžç®ç*ã§ãïŒ90ïŒ ïŒããã®ã¿ã€ãã®çã¯ãéåžžèè±å è ãæ§æããŠã
ã移è¡äžç®*ãŸãã¯å°¿è·¯äžç®*ãšåŒã°ãã现èããçºçããŸãããã®ä»ã®ã¿ã€ããšããŠã¯ãè
è±å è ã®æå¹³ã§èã现èããçºçããæå¹³äžç®çããç²æ¶²ãç£çãã现èããçºçããè ºç
*ããããŸãããã以å€ã®ãŸããªã¿ã€ãã®èè±çãååšããŸãããã®æåŒãã§ã¯ç§»è¡äžç®ç
ã«ã€ããŠèª¬æããŠãããŸãã
ç·æ§ïŒå·Šå³ïŒãšå¥³æ§ïŒå³å³ïŒã®å°¿è·¯ïŒè èã尿管*ãèè±ãå°¿é*ïŒè§£åå³ã瀺ããŸããå°¿ã¯å°¿çŽ°ç®¡*ã§çæããã
è ç*ã«éããããŸãããã®å°¿ã¯ãè èãã尿管ãéã£ãŠèè±ãžãšæµããŠãããŸããå°¿éãéã£ãŠäœå€ãžæå°¿ã
ãããŸã§ãå°¿ã¯èè±ã«è²¯ããããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 7
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
èè±çã®é »åºŠã¯ïŒ
2012 幎ããšãŒãããã§ã¯ 151,297 人ã®æ£è ãããèè±çãšèšºæãããŸããããšãŒãã
ãã§ã¯èè±ç㯠5çªç®ã«é »åºŠãé«ãçã§ãã
èè±çã¯ç·æ§ã«ãããŠå¥³æ§ãããçŽ 5 åé »åºŠãé«ããšãããŠããŸãã2012 幎ã«ã¯ç·æ§ã§
10 äžäººäž 17.7 人ã女æ§ã§ 3.5 人ãèè±çã«çœ¹æ£ããŸãããç·æ§ã§ã¯ 4 çªç®ã«é »åºŠãé«ãã
女æ§ã§ã¯ 13çªç®ã«é »åºŠãé«ãçã§ãã
EU è«žåœã§ã¯ãç涯ã«ããã£ãŠã®ç·æ§ã®èè±ç眹æ£ç㯠1.5 ãã 2.5ïŒ ãšãããŠããŸããã
ã«ã®ãŒã®ãã©ã³ãã«å°æ¹ããã«ã¿ãã¹ãã€ã³ãã€ã¿ãªã¢ã§ã¯ããã«çœ¹æ£çãé«ãã3.1 ãã
4.2ïŒ ãšãããŠããŸããç涯ã«ããã£ãŠã®å¥³æ§ã®èè±ç眹æ£çã¯ã1ïŒ æªæºã§ãã
èè±çã®çœ¹æ£çã¯ã幎霢ãšãšãã«é«ããªããŸããèè±çæ£è ããã® 70ïŒ ã¯ã65 æ³ä»¥éã«
çç¶ãåºçŸããŠããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 8
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
èè±çã®åå ã¯ïŒ
çŸåšãèè±ççºçã¡ã«ããºã ã¯ãŸã å®å šã«ã¯å€æããŠãããŸãããå€ãã®çºçå åãåå®ã
ããŠããŸãããå€ãã®æ£è ããã®çºçã«ãããŠãããã¯é¢äžããŠããªããšèããããŸããå±
éºå å*ã¯çãçºçãããããšããããŸãããçºçã«ãããŠå¿ èŠååæ¡ä»¶ã§ã¯ãããŸããã
å±éºå åã¯ããã ãã§ã¯åå ãšãªãããŸããã
å±éºå åãæã€äººãèè±çã«ãªããªãããšãããã°ãå±éºå åãæããªãã«ããããããè
è±çã«ãªãããšããããŸãã
äž»ãªèè±çã®å±éºå åã¯ä»¥äžã®éãã§ã:
- é«éœ¢ïŒèè±çã¯ããé«éœ¢è ã«çºçããŸããèè±çæ£è ããã® 70ïŒ
ã¯ã65 æ³ä»¥éã«èšºæãããŠããŸãã
- èè±çã®æ¢äœã
- å«ç ïŒå«ç ã¯èè±çã®æãéèŠãªå±éºå åã§ãã4 幎以äžçŠç ã
ãããšã«ãããèè±çã®ãªã¹ã¯ãäœæžãããããšãã§ããŸãã
- å€ãã®ååŠç©è³ªãèè±ççºçã®åå ãšããŠç¥ãããŠããŸã:
o ã¢ããªã³è²çŽ ïŒæç¹ç©ã«å«ãŸããååŠç©è³ªã§ãã
o ã·ã¯ããã©ã¹ãã¡ããïŒçæ²»çã«çšããããååŠçæ³*ã®è¬å€ã§ãã
o è³éŠæã¢ãã³ïŒè³éŠæã¢ãã³ãžã®æŽé²ã¯ããã³ããé©ãéå±ã補çŽããŽã å·¥
å Žã®ä»ããã©ãã¯é転æãã¯ãªãŒãã³ã°å±ãæ¯ç§æ工士ãç容垫ãªã©æ§ã ãª
è·çš®ã§èµ·ããããŸããæŽé²åŸ 30 ãã 50 幎çµéããŠããçºçãããšãããŠ
ããŸãã
o ãçŽ ïŒå°æ¹Ÿã®æ°Žã¯ãçŽ æ¿åºŠãé«ããèè±çã®çºççã®é«ãã®åå ãšãããŠã
ãŸãã
o åºé²å·²ïŒãã€ãšããçšã®ãµããªã¡ã³ãã挢æ¹æ²»çã«ãŠçšãããã挢æ¹è¬ã§ãã
ãã®æŒ¢æ¹è¬ãééã£ãŠæ··å ¥ãããã€ãšããçšãµããªã¡ã³ãã䜿çšãã人ã«ã
èè±çãå¢å ããããšãç¥ãããŠããŸãã
- æŸå°ç·ïŒåç«è º*çæ²»çã®éãªã©ã®é»é¢æŸå°ç·*ãžã®èè±ã®æŽé²ããèè±çã®ãªã¹ã¯
ãäžæããããšèããããŠããŸãã
- ããã€ãã®å±éºå åã¯ç¹ã«æå¹³äžç®ç*ãšããç¹æ®ãªã¿ã€ãã®èè±çã«ãããŠéèŠã§
ãããã®è «çã¯ãèè±ã®æ ¢æ§çãªåºæ¿ãççã«ãã£ãŠçºçããŸãã欧米人ã«ããã
æå¹³äžç®çã®äž»ãªå±éºå åãšããŠã¯ãèè±æ©èœé害ãé·æèè±ç眮ã«ããŒãã«*ãè
è±çµç³ãæ ¢æ§èè±çãæããããŸããã¢ããªã«ãäžæ±ã§ã¯æå¹³äžç®çã®å±éºå åãš
ããŠããã®å°åã«çæ¯ãããã«ãã«ãäœè¡åžè«ææãç¥ãããŠããŸãããã®åŸ®çç©
ã¯èè±ã«ææããæ ¢æ§ççãåŒãèµ·ãããŸãã
- ç³å°¿ç *ïŒã¿ã€ã 2 ç³å°¿ç æ£è ããã¯ãèè±ççºççãé«ããªããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 9
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
ä»ã®ä»¥äžå±éºå åãèè±ççºçã«é¢äžããŠããããšãçãããŠããŸããããŸã ãšããã³ã¹
ïŒç§åŠçæ ¹æ ïŒã¯ç¢ºç«ããŠããŸãã:
- ã³ãŒããŒã人工çå³æãã¢ã«ã³ãŒã«ïŒããããããç©è³ªã®èç©ããèè±ççºçã®ãª
ã¹ã¯ãäžæããããšããæãããªèšŒæ ã¯ãããŸããã
- é«æ¿åºŠã®ããªããã¡ã¿ã³ãå«ãæ°Žéæ°ŽïŒãããã®ååŠç©è³ªã¯ãå¡©çŽ æ¶æ¯ã®éã«çæ
ãããŸããããã€ãã®ç 究ã«ãããŠããã®ãããªæ°Žéæ°Žãé·æéæåããããšã«ã
ãèè±çã®ãªã¹ã¯ãäžæãããšç€ºãããŠããŸãããããããã®èšŒæ ã¯æããã§ã¯ã
ããŸããã
- éºäŒïŒèè±çã®å®¶ææŽãããå Žåããããã«èè±çã®çºççãé«ããªããŸãããã
ããéºäŒæ§æ¬ æéºäŒåã«äŒŽãèè±çã¯éåžžã«ãŸãã§ãã
- äœéïŒè¥æºãèè±çã®å±éºå åãšãªããšç€ºããŠããç 究ãäžã€ãããŸãããããä»
ã®ç 究ã§ã¯ç¢ºèªãããŸããã§ããã
以äžããã€ãã®å åã¯ãçºçæå¶ã«é¢äžããå¯èœæ§ããããŸãããããããŸã ãšããã³ã¹ã¯
確ç«ããŠããŸããã
- æ°ŽåæåïŒç·æ§ã§ã¯ãæ°Žåãå€ãæåããããšã«ããèè±çã®ãªã¹ã¯ãäœæžããã
ãããããªããšæå±ãããŠããŸãããããç 究ã«ãã£ãŠçµæã¯ãŸã¡ãŸã¡ã§ãã
- æç©ãéèïŒæç©ãéèã®æåããããšã«ãããèè±çäºé²å¹æããããšããããŠ
ããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 10
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
èè±çã®èšºæã¯ïŒ
èè±çã¯æ¥åžžçãªäœã®ãã§ãã¯ã§çºèŠãããããç¹åŸŽçãªçç¶ãããšã«çããããããŸãã
ãã®äž»ãªçç¶ã¯ã以äžã®ãšããã§ã:
è¡å°¿ïŒéåžžçã¿ã¯ãªããèè±çæ£è ã® 85ïŒ ã«èŠãããŸãã
æå°¿é害ïŒæ®æ®µãããå°¿ã®åæ°ãå€ãïŒé »å°¿ïŒããããŠãŠæå°¿ããªããã°ãªããªã
ïŒå°¿æåè¿«ïŒãæå°¿ããæã®çã¿ïŒæå°¿æçïŒãªã©ãèµ·ããããŸãã
ãããããããã®çç¶ã¯èè±çã ãã§ã¿ããããã®ã§ã¯ãªããå°¿è·¯ææçãè çµç³ãåç«è º
è¥å€§ç*ãªã©ã®ç以å€ã®çŸæ£ã§ãã¿ãããŸãã
èè±çã¯è èããã®å°¿ã®éãéããµããããšããããŸãããã®å Žåãè èã«å°¿ãããŸãããš
ã§è èã®æ¡åŒµïŒæ°Žè çïŒãçã¿ãåŒãèµ·ããããšããããŸãã
å»åž«ã¯äžèšã®ãããªçç¶ã確èªãã以å€ã«ãäžè¬çãªèº«äœèšºå¯ããè¡çæåãè æ©èœã枬ã
ããã®æ¡è¡æ€æ»ãè¡ããŸãã
èè±çã®èšºæã¯ä»¥äžã®æ€æ»ã«åºã¥ããŠè¡ãããŸã:
1. 身äœèšºå¯*
身äœèšºå¯ã«ãããèè±çããã®ä»ã®å¥åº·çãªåé¡ã®å åã
ããããŸããå»åž«ã¯èè±è «çã®å€§ãããåºããã調ã¹ãã
ãã«ãçŽè žèšºã女æ§ã®å Žåã¯å 蚺ãè¡ããŸãã
2. èè±é¡æ€æ»*
èè±é¡æ€æ»ã¯å èŠé¡ãçšãã蚺å¯ã§ããå»åž«ã¯èè±ã
å°¿éå ã®è «çã®æç¡ã調ã¹ãããã«ãå°¿é*ã®åºå£ãã
å æºã€ãã«ã¡ã©ãæ¿å ¥ããŸããèè±é¡æ€æ»ã¯èšºå¯å®€ã§
è¡ãããé垞麻é *ã¯å±æ麻é ã®ãŒãªãŒã§ååã§ããã
ããæã«ãå šèº«éº»é *äžã«åæ蚺ãè¡ããªããèè±é¡æ€
æ»ãè¡ãããšããããŸãã
èè±é¡ãéããŠæ¿å ¥ããåšå ·ãçšããŠãè «çãçãã
ãç®æããçµç¹ãæ¡åããŸãããã®æ€æ»ã¯çæ€*ãšåŒã³
ãŸããèè±çã§ééããªãè «çã«å¯ŸããŠã¯ããã¿ãã
ã«è «çå šäœãåé€ããŸãããã®åŠçœ®ãçµå°¿éçèè±è «çåé€è¡ïŒTURBTïŒ*ãšåŒã³
ãŸããã€ãŸãèè±é¡æ€æ»ã¯èè±çæ²»çã®ç¬¬äžæ©ãšãããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 11
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
å Žåã«ãã£ãŠã¯ãå»åž«ã¯å°¿ç®¡ãæ€æ»ããŸããããã®æ€æ»ã¯å°¿ç®¡é¡æ€æ»*ãšãããŸãã
èè±é¡ã䜿çšããŠãå°¿é*ããçæ€ãè¡ãããšããããŸãã
3. 尿现è蚺*
尿现è蚺æ€æ»ãšã¯ãå°¿äžã«è «ç现èãååšããŠããã®
ãã調ã¹ãæ€æ»ã§ãã
4. ç ççµç¹æ€æ»*
è «ççµç¹ãé¡åŸ®é¡äžã«èª¿ã¹ãæ€æ»ã§ããèè±é¡*ãçšã
ãŠè «çããæ¡åãããçæ€æ€äœã«å¯ŸããŠè¡ããŸããç ç
çµç¹æ€æ»*ã«ããèè±çãšã®èšºæã確å®ããåã ã®è «ç
ã®ç¹åŸŽãæãããšãªããŸããããã«ããå»åž«ãèè±çã®
ã¿ã€ãã決å®ããããšãã§ããŸãã
ãããèè±é¡æ€æ»ã®åŸã«æè¡ïŒãããŠãã¯åè¿°ã® TURBTïŒ*ãè¡ãå Žåã«ã¯ããã®
æã«æã«å ¥ããè «çæ€äœãçšã㊠2 åç®ã®ç ççµç¹æ€æ»ãè¡ãããŸããååã®çæ€*
ã®çµæã確èªããããã«ãšãŠãéèŠãªæ€æ»ã§ãããããã«ããçã®ããæ£ç¢ºãªæ å ±ã
ã¹ããŒãžãããããŸãã
5. æŸå°ç·èšºæ*
ãããç ççµç¹æ€æ»*ã§è «çãèè±ã®ããæ·±
ãå±€ïŒçå±€ïŒãžé²å±ããŠãããšããã£ããã
è «çãã©ã®å±€ãŸã§é²å±ããŠããããèè±å€ã®
ãªã³ãç¯*ã«ãŸã§é²å±ããŠãããã調ã¹ãã
ãã«æŸå°ç·èšºæãè¡ãå¿ èŠããããŸãã
æŸå°ç·èšºæã«ã¯ã¹ããŒãžåé¡*ãšãã圹å²ã
ãããè ¹éšã骚ç€ã® CT ã MRI*ãçšããã
ãŸãã2.5%ã®æ£è ããã§ã¯äžéšå°¿è·¯ã«è «ç
ãåæã«ååšãããããCT Urogram ãçµ
éèè çé 圱ãéè¡æ§è çé 圱ïŒè ãèè±ã尿管ã®ç¹æ®ãªã¬ã³ãã²ã³æ€æ»ïŒãè¡ã
ããŸãã転移ã®å±éºãé«ãæ£è ããã§ã¯èžéš CT*ãªã©ã®è¿œå ã®æ€æ»ãè¡ããããŸã
è «çã骚ãŸã§åºãã£ãŠãããããªçç¶ãããå Žåã«ã¯ã骚ã·ã³ãã°ã©ãã£æ€æ»*ãè¡
ãããšããããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 12
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
é©åãªæ²»çãåããã«ã¯äœãéèŠãïŒ
å»åž«ã¯æåã®æ²»çæ³ãè¡ãäžã§ãæ£è ãããšçåæ¹ã®åŽé¢ãèæ ®ããå¿ èŠ
ããããŸãã
æ£è ããåŽã®æ²»çæ¹éã«é¢é£ããæ å ± æ§å¥
æ¢åŸæŽãšå æè¬
è¡çžè ã§ã®èè±çã®æ¢äœ
å¥åº·ç¶æ ãçç¶
身äœèšºå¯*ã®çµæ
è¡æ¶²æ€æ»ãè æ©èœãèæ©èœæ€æ»ã®çµæ
çã®æ²»çæ¹éã«é¢é£ããæ å ±
ã¹ããŒãžåé¡*
å»åž«ã¯çã®é²å±ãæ£è ããã®äºåŸãè©äŸ¡ããããã«ã¹ããŒãžåé¡ãè¡ããŸããããã®éã«ã¯
TNM åé¡ãããçšããããŸããè «çã®å€§ãããšè¿æ¥çµç¹ãžã®æµžæœ€*ïŒTïŒããªã³ãç¯*ãžã®
転移ïŒNïŒãäœã®ä»ã®éšäœãžã®è»¢ç§»*ãããã¯åºããïŒMïŒãçµã¿åãããŠåŸã«èšèŒããŠã
ãã¹ããŒãžã«åé¡ããŸãã
ã¹ããŒãž*ã¯æ²»çã«ã€ããŠæ£ãã決å®ãããããã®åºç€ãšãããŸããããäœãã¹ããŒãžã§ã¯
äºåŸã¯è¯ããªããŸããã¹ããŒãžåé¡ã¯èšåºæ€æ»ãæŸå°ç·èšºæ*ãçæ€*ã«ããç ççµç¹æ€æ»ã
çµäºããæç¹ã§è¡ãããŸããããæè¡ãè¡ãããã®ã§ããã°ã2 åç®ã®ã¹ããŒãžåé¡ãæè¡
æ€äœã®ç ççµç¹æ€æ»çµæã«åºã¥ããŠè¡ãããŸãã
次ã®è¡šã¯èè±çã®ã¹ããŒãžã瀺ããŠããŸããå®çŸ©ã«ã¯å°éçãªçšèªãå«ãŸããããã詳现ã¯
å»åž«ã«ç¢ºèªããããšãããããããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 13
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
ã¹ããŒãž å®çŸ© (äžã®èè±å£ã®å³ãåç §) ã«ããŽãªãŒ
ã¹ããŒãž 0a é浞最æ§ä¹³é ç¶ããïŒç²èäžç®*ã«éå±ããŠããè «ç çå±€é
浞最æ§
èè±ç
ã¹ããŒãž 0is å¹³åŠãªè «çïŒäžç®å çïŒïŒç²èäžç®*ã«éå±ããŠãããæªæ§
床ãé«ãè «ç
ã¹ããŒãž I ç²èåºæå±€*ãŸã§æµžæœ€ããŠããè «ç)
ã¹ããŒãž II èè±ã®çèãŸã§æµžæœ€ããŠããè «çã§ããã« 2 ã€ã«åé¡ãã
ã:
T2a: 浞最ãèè±ã®çèã®åå以äž
T2b: 浞最ãèè±ã®çèã®åå以äž
ç局浞最æ§
èè±ç
ã¹ããŒãž III èè±åšå²ã®çµç¹ãŸã§æµžæœ€ããŠããè «çãããã« 3 ã€ã«åé¡ã
ãã:
T3a: é¡åŸ®é¡åŠç浞最*
T3b: èçŒç浞最*
T4a: èè±åšå²èåšãžã®æµžæœ€ïŒç·æ§ãªãåç«è º*ã女æ§ãªãå
å®®ãè£
ã¹ããŒãž IV 骚ç€å£ãè ¹å£ã«æµžæœ€ããŠããè «çããããã¯ãªã³ãç¯ãèè±
ããé éã®èåšãžè»¢ç§»*ããŠããè «ç
é²è¡æ§
転移æ§ç å€
èè±å£ã®å±€ã¯ç²è*ïŒç²èäžç®*ãšç²èåºæå±€*ïŒãšçå±€ã§æãç«ã£ãŠããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 14
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
çæ€*ã®çµæ
è «ççæ€ããåŸãããæ€äœã¯ç çå»ã«ãã£ãŠæ€æ»ãããŸãããã®æ€æ»ãç ççµç¹æ€æ»*ãšåŒ
ã³ãŸããèè±é¡æ€æ»*åŸã«æè¡ãè¡ã£ãå Žåãç ççµç¹æ€æ»ã¯æè¡ã§æ¡åããè «çããªã³ã
ç¯*ã®æ€æ»ãå«ãã§ããŸãããã®ããã«ååã®çæ€çµæã確èªããããšã¯ãšãŠãéèŠã§ããã
ããã®ã¹ããŒãžã®ãããªãæ å ±ã«ã€ãªãããŸããçæ€çµæã¯ä»¥äžã®ãã®ãå«ã¿ãŸã:
o çµç¹åŠçã¿ã€ã*
çµç¹åŠçã¿ã€ããšã¯è «çãæ§æãã现èã®çš®é¡ã®ããšã§ãã90%ã®èè±çã¯ç§»è¡
äžç®ç*ã§ãããã®æåŒãã§ã¯ç§»è¡äžç®çãšåŒã³ãŸãããå°¿è·¯äžç®çãšåŒã°ããã
ãšããããŸããããã¯ç§»è¡äžç®*ããçºçããè «çã§ãã移è¡äžç®ã¯èè±äŒžçž®ã®ã
ã³ã«åœ¢ãå€ããããšãã§ããããå€ãã®å±€ã«ãã圢æããããèè±å£ã®æãå åŽ
ã«ããäžç®ã§ãã
æ®ãã® 10%ã®å€ãã¯æå¹³äžç®ç*ãšè ºç*ã§ããããã以å€ã®çµç¹åã¯æ¥µããŠãŸã
ã§ãã
o æªæ§åºŠ*
æªæ§åºŠã¯æ£åžžèè±ã§ã¿ãããäžç®çŽ°èãšãæèŠãã©ã®çšåºŠç°ãªãããèŠãããšã«
ãã決ããããŸããç°åžžã匷ãã»ã©çŽ°èå¢å ã浞最ã®åŸåã匷ããªããŸããèè±
çã«ã¯ä»¥äžã® 4 ã€ã®æªæ§åºŠããããŸã:
ä¹³é è «ïŒæªæ§ã§ãªã现èããæ§æãããè «çã
äœæªæ§åºŠä¹³é ç¶å°¿è·¯è «çïŒæªæ§ã§ãªã移è¡äžç®*ã®åãå±€ã«ãã£ãŠæ§æããã
è «çã
äœæªæ§åºŠã®å°¿è·¯äžç®çïŒæé·ãé ãåºããã«ããæªæ§è «çã
é«æªæ§åºŠã®å°¿è·¯äžç®çïŒæé·ãæ©ãåºãããããæªæ§è «çã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 15
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
æ²»çã®éžæè¢ãšããŠäœãããã®ïŒ
åç«è ºçã®æ²»çèšç»ã¯ãè€æ°ã®é åã®å°é家ãéãŸã£ãããŒã ãšãšãã«
è¡ãããŸããããŒã ã¯éåžžãå€è·çš®ããŒãã£ã³ã°*ãããã¯ãã£ã³ãµãŒã
ãŒã*ãšããäŒè°ãè¡ããŸãããã®äŒè°ã§ã¯ãäžè¿°ããèè±çã®é¢é£æ å ±
ã«åºã¥ããŠæ²»çèšç»ãåè°ãããŸãã
æ²»çã¯éåžžãäžèšã®çæ³ãçµã¿åãããŠè¡ãããŸã:
æè¡çæ³ãæŸå°ç·çæ³*ãå±æååŠçæ³*ãå±æå ç«çæ³*ãªã©ã®å±
æçã«äœçšããæ²»ç
å šèº«ååŠçæ³ã«ãããäœå šäœã«ååšããç现èã«äœçšããæ²»ç
æ²»çã®è©³çŽ°ã¯çã®ã¹ããŒãžãè «çã®ç¹æ§ãæ£è ããã®ãªã¹ã¯ã«å¿ããŠæ±ºå®ãããŸãã
以äžã«èšèŒããŠããæ²»çæ³ã¯ãããããã«å©ç¹ããªã¹ã¯ãçŠå¿*ããããŸããæ²»ççµæã«ã€
ããŠç¥ãããã«ãæ²»çæ³ããããã®å©çããªã¹ã¯ã«ã€ããŠå»åž«ã«çžè«ããããšããå§ãããŸ
ããããã€ãã®æ²»çæ³ã«ãããŠã¯ãéžæè¢ãè€æ°ãããã®ããããŸããæ²»çæ³ã®éžæã¯ãå©
çãšãªã¹ã¯ã®ãã©ã³ã¹ã«å¿ããŠçžè«ããŠããå¿ èŠããããŸãã
çå±€é浞最çïŒã¹ããŒãž 0aãã¹ããŒãž 0isãã¹ããŒãž IïŒãžã®æ²»ç
ãããã®ã¹ããŒãžã§ã¯ãè «çã¯èè±å£ã®è¡šå±€ïŒç²è*ïŒã«éå±ããçå±€ã«ã¯æµžæœ€ããŠããŸãããæ²»çã®äž»ããç®æšã¯ãTURBT æè¡ã«ããéå±ããçãåãé€ãããšã«ãªããŸããããããªãããèè±ãžã®è£å©çæ³ïŒèè±å æ³šå ¥çæ³ãšåŒã³ãŸãïŒããè «çåçºããã³é²è¡ã®ãªã¹ã¯ãæããããã«è¡ãããšãæšå¥šãããŠããŸãã è£å©çæ³ã®ã¿ã€ãã¯ãè «çã®é²è¡*åã³åçº*ã®ãªã¹ã¯ã«ãã決ãŸããŸããã¹ããŒãž 0a ããã³ã¹ããŒãž I ã®æ£è ããã®ããããªã¹ã¯ã¯ãããã€ãã®è «çã®ç¹åŸŽãçµã¿åãããã¹ã³ã¢ãªã³ã°ã·ã¹ãã ã«ããç®åºããããšãã§ããŸãã
èè±é¡*ãšçµå°¿éçèè±è «çåé€è¡ïŒTURBTïŒ*
èè±é¡æ€æ»ã®åŸãå šãŠã®æ£è ããã« TURBT*ãè¡ãããŸããå€ãã®å Žåã§ã¯è «çã¯å®å š
ã«åé€ããããšãã§ãããã®å Žå㯠TURBT*ãæã確å®ãªæ²»çã«ãªããŸããèè±ã«çŽæ¥
è¬å€ãæäžããèè±å æ³šå ¥çæ³ãšããè¿œå æ²»çïŒè£å©çæ³*ãšåŒã³ãŸãïŒãæšå¥šãããã
ãšããããŸããè£å©çæ³ã®ã¿ã€ãã¯ãæ£è ããããããã®åçºåã³é²è¡ã®ãªã¹ã¯ã®ä»ã
è£å©çæ³ã«äŒŽãå¯äœçšãžã®æ£è ããã®èæ§ãèæ ®ããŠæ±ºå®ãããŸãã
ãã€ãªã¹ã¯ãªè «çã§ãã£ãæ£è ããã«ã¯ãæ®åè «çã®æç¡ã確èªããããæ£ç¢ºã«ã¹ããŒ
ãžã³ã°ãè¡ãããã«ãèè±å æ³šå ¥çæ³ã®åãåŸã«ã»ã«ã³ã TURBT*ãæšå¥šãããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 16
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
èè±å *ååŠçæ³*ã»èè±å å ç«çæ³*
åçºãšé²è¡*ã®ãªã¹ã¯ãæãããããTURBT*ãåããå šãŠã®æ£è ããã«ã¯ãæè¡ã®çŽåŸã«
ååã®èè±å æçå€æ³šå ¥ãè¡ãããŸããã»ãšãã©ã®å Žåã¯ãèè±å ã«æ³šå ¥ããæçå€ãšããŠ
ãã€ããã€ã·ã³C*ãçšããããŸããããšãã«ãã·ã³*ããããœã«ãã·ã³*ã䜿çšãããŸãã
è «çåçºãšé²è¡ã®ãªã¹ã¯ãäœãæ£è ããã§ã¯ãååã®èè±å æ³šå ¥ã§æ²»çãå®äºããŸãã
è «çé²è¡ã®ãªã¹ã¯ãäžçšåºŠããé«åºŠãšèããããæ£è ããã«ã¯ãè€æ°åã«æž¡ãæçå€ã®
æ³šå ¥çæ³ããã㯠BCG*ã®æ³šå ¥ã«ããèè±å å ç«çæ³ããããªãããŸãïŒäžèšåç §ïŒã
æçå€ãšå ç«çæ³ã®ããããéžæãããã¯ãããããã®æ£è ããã®ãªã¹ã¯ã«å¿ããŠæ±ºãŸ
ããŸããæçå€ã®æ³šå ¥ã¯ïŒå¹ŽæªæºãéäŸã§ãããå ç«çæ³*ã®å Žåã¯æäœã§ãïŒå¹Žã¯ç¶ç¶
ãããŸãã
BCG (Bacillus Calmette-Guérin)*ã«ããèè±å *å ç«çæ³*
ãªã¹ã¯ãé«ãæ£è ããã§ã¯ãBCG èè±å æ³šå ¥çæ³ãæšå¥šãããŸããBCG ã¯çµæ žäºé²ã®
ã¯ã¯ãã³ã§ããBCG ãã©ã®ããã«èè±çãžäœçšããã®ãã¯ãããŸã解æãããŠãããŸã
ããBCG ã¯ãç现èã殺ããããªå ç«åå¿ãåŒãèµ·ãããšèããããŠããŸãããã®ããã
BCG ã«ããæ²»çã¯å ç«çæ³*ãšããŠãšãããããŠããŸããéåžžã¯ãå°å ¥çæ³ããšåŒã°ã
ãïŒé±éã®æ²»çãæåã«åããåŸããç¶æçæ³ããšåŒã°ããæ²»çãæäœïŒå¹Žéç¶ããŸãã
2 幎éç¶æçæ³ãç¶ããæ²»çèšç»ããããŸãã
èè±å šæè¡*
ã¹ããŒãž 0isãã¹ããŒãž I ã§ãèè±å *æ³šå ¥çæ³*ãç¡å¹ãªå Žåã«ã¯ãèè±å šæè¡ãå§ãã
ããŸãã
ç局浞最çïŒã¹ããŒãž IIãIIIïŒãžã®æ²»çèšç»
ãã®ã¹ããŒãžã§ã¯ãè «çã¯èè±ã®çå±€ãžãšæµžæœ€ããŠãããããããã¯èè±ã®å£ãè¶ããŠãèè±åšå²ã®èèªçµç¹ã«ãŸã§éããŠããŸãããã®å Žåã¯èè±ã骚ç€å ã®ãªã³ãç¯*ããã³èè±è¿åã®èåšãæè¡ã«ããåãé€ããŸããè «çã®çž®å°ããç»åæ€æ»ã§èŠããªããããªå°ããªè»¢ç§»æ§è «çãžã®æ²»çãæè¡ã®éã®ç现èã®è»¢ç§»*ã®ãªã¹ã¯ãæžå°ãããããšãç®çãšããŠãæè¡ã«å ç«ã£ãŠååŠçæ³*ãè¡ãããŸãã
èè±å šæè¡*
ç局浞最èè±çã®æšæºçãªæ²»çã®äžã€ã«èè±å šæè¡ããããŸãã
ç·æ§ã®å Žåã¯èè±å šäœãšç®ã«èŠããè «ççµç¹ã ãã§ãªããå°¿é*ã
åç«è º*ã粟å¢*ã尿管*äžéšã骚ç€å ãªã³ãç¯*ãæåºããŸãã女
æ§ã®å Žåã¯ãèè±å šæã®éã«èè±å šäœãšç®ã«èŠããè «ççµç¹ã®ä»ã
å°¿éã尿管äžéšãè *ãåå®®*ã骚ç€å ãªã³ãç¯ãæåºããŸãã
æ£è ããã«ãã£ãŠã¯ããã®è¡åŒãå°ãå€æŽããŠãç¹å®ã®èåšãæž©
åããå ŽåããããŸããæž©åãã§ãããã©ããã¯ãè «çã®åºãã
ã®çšåºŠã«ããã®ã§ãåã ã®æ£è ããããšã«æ éã«è©äŸ¡ããå¿ èŠã
ãããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 17
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
èè±å šæè¡*åŸã¯ãå°¿ã貯ãããšããèè±ã®æ©èœã倱ãããŸãããã®ããæè¡ã®éã«ã¯å°¿
è·¯å€æŽ*ãšãã£ãŠã尿管*ãæ°èŠã®å°¿æåºçµè·¯ã«ã€ãªããåŠçœ®ãè¡ããŸãããã®ãããªæ°
èŠã®ææ³è·¯ã¯å°¿é*ãè ¹éšã®ç®èãå€§è žã®æ«ç«¯(çŽè ž S ç¶éšå°¿è·¯å€æŽãšãããŸã)ã«é ãã
ãŸããã©ã®ãããªå°¿è·¯å€æŽã«ãªãã®ãã¯ãè «çã®ã¹ããŒãžãèè±å šæåŸã«æž©åã§ããçµ
ç¹ãæ£è ããã®å šèº«ç¶æ ãæ£è ããã®è¶£åãªã©æ§ã ãªèŠçŽ ã§æ±ºããããŸãããã®ä»ã®éž
æè¢ã«ã€ããŠã¯ãæ²»çã®å¯äœçš*ãã®é ç®ã§åŸè¿°ããŸãã
ããã«èè±å šæè¡ã«ã¯çæ®é¢é£èåš*ã®æåºãå«ãŸãããããæè¡ã«ããæ§æ©èœé害*ã«
ãªã£ãããçæ®æ©èœ*ãåªå€±ãããããããšããããŸãïŒæ²»çã®å¯äœçšãåç §ããŠãã ã
ãïŒã
ååŠçæ³*
ã¹ããŒãž T2ã T3 ã®æ£è ããã«ã¯ãè¡åååŠçæ³ïŒããªã¢ãžã¥ãã³ãååŠçæ³*ïŒãæš
奚ãããŸããèè±å šæè¡*ãããã¯æŸå°ç·çæ³*ã®åã«ãè€æ°ã®æçå€ãçµã¿åãããŠæ
äžããŸããæšå¥šãããçµã¿åããã¯ãã²ã ã·ã¿ãã³*ãšã·ã¹ãã©ãã³*ïŒGCïŒãããã¯ã¡
ãœãã¬ãã»ãŒã*ããã³ãã©ã¹ãã³*ããããœã«ãã·ã³*ãã·ã¹ãã©ãã³*ïŒMVACïŒã® 2
çš®é¡ã§ããããªã¢ãžã¥ãã³ãååŠçæ³ã®çãã¯ã埮å°ãªè»¢ç§»*ã®æ ¹çµ¶ãè «çã®çž®å°ãæè¡
ã®éã«è «ç现èãåºãã£ãŠããŸããªã¹ã¯ã®äœæžãªã©ã§ãã
æŸå°ç·çæ³*
æŸå°ç·åç¬çæ³ã¯ãèè±å šæè¡*ã®ãããªå€§æè¡ã«èããããªããããª
æ£è ããã§æ€èšãããããšããããŸãã
ãŸããäžå®ã®æ¡ä»¶ãæºãããæ£è ããã«å¯ŸããŠé©å¿ãšãªããèè±æž©å
çæ³ïŒåŸã®ãèåšæž©åæ²»ç*ãåç §ïŒã®äžç°ãšããŠè¡ãããããšããã
ãŸãã
èåšæž©åæ²»ç*
èåšæž©åæ²»çã¯ãèè±ãæž©åããæ²»çãæããŸããããã¯ãèè±å šæ
è¡*ãåžæãããªãæ£è ããããèè±å šæè¡ã®ãããªå€§æè¡ã«å»åŠçã«
èããããªããšèããããæ£è ããã«ææ¡ãããŸãããã®æ²»çã«ã¯ãaggressive
TURBT*ãTURBT*ãšååŠçæ³*ãããã¯æŸå°ç·çæ³*ã®äœµçšçæ³ãTURBT*ã»æŸå°ç·ç
æ³ã»ååŠçæ³ã® 3 皮䜵çšçæ³ãªã©ããããŸããæåŸã® 3 皮䜵çšçæ³ã¯ããªã¢ããªãã£æ²»
çãšåŒã°ããæšå¥šãããŠããŸãã
èåšæž©åæ²»çã¯ãæ²»çé©å¿æ¡ä»¶ãæºãããæ©æèè±çã®æ£è ããã«èæ ®ãããããšãã
ããŸãã
èåšæž©åçæ³ã®æ²»çåŸã¯ãç涯ãéããŠç¶¿å¯ãªãã©ããŒã¢ãã*ãå¿ èŠã§ããèè±é¡*ã
ãã³å°¿çŽ°è蚺*ã§ãæ²»çã®åå¿æ§ãšè «çåçºã®è©äŸ¡ãè¡ããŸããæ²»çæµææ§ãããã¯åçº
æ§ã®è «çãæ€åºãããæã«ã¯ãå¯èœã§ããã°å³æã«èè±å šæè¡ãè¡ããŸãã
é²è¡æ§ã»è»¢ç§»æ§*èè±çïŒã¹ããŒãž IVïŒã®æ²»ç
ãã®ã¹ããŒãžã§ã¯ãæ²»çã¯èè±å£ãè¶ãã骚ç€å£ãããã¯è ¹å£ãžãšéããŠããããå€èåšã«åãã§ããŸããæè¡ã«ããè «çã®å®å šãªæåºã¯é£ãããå»åŠçã«é©å¿ã§ã¯ãªããããå šèº«ã«å¹æã®ããååŠçæ³ãç¹æ»Žã§è¡ããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 18
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
ååŠçæ³*
æšæºçãªæçå€ã®çµã¿åããã¯ãã²ã ã·ã¿ãã³*ãšã·ã¹ãã©ã
ã³*ïŒGCïŒãããã¯ã¡ãœãã¬ãã»ãŒã*ããã³ãã©ã¹ãã³*ãã
ããœã«ãã·ã³*ãã·ã¹ãã©ãã³*ïŒMVACïŒã® 2 çš®é¡ã§ãã
MVAC ã¯ãGC ã«æ¯ã¹ãŠå¯äœçšãéããªããŸããéå±çãªè»¢
移ã®ïŒãªã³ãç¯*転移ã¯ãããèåšã®è»¢ç§»*ãæããªãïŒæ£è ã
ãã«ã¯ãé«å®¹é MVAC ãšãG-CSF ãšåŒã°ããçœè¡çã®å¢æ®
å åã®äœµçšçæ³ãè¡ãããšããããŸããG-CSF ã¯ãååŠçæ³
ãžã®æ£è ããã®èæ§ãäžããå¹æããããŸãã
ãããåæ°ã®æ£è ããã¯ãå šèº«ç¶æ ã®äžè¯ãè æ©èœé害ãä»ã®çŸç ãªã©ã§ã·ã¹ãã©ãã³
ã®é©å¿ãšãªããŸããããã®ãããªæ£è ããã«ã¯ãã«ã«ããã©ãã³*ã»ã²ã ã·ã¿ãã³*䜵çš
çæ³ïŒCarboGemïŒãã¡ãœãã¬ãã»ãŒã*ãã«ã«ããã©ãã³*ã»ãã³ãã©ã¹ãã³*䜵çšç
æ³ïŒM-CAVIïŒãã¿ããµã³*ç³»æçå€ãããã¯ã²ã ã·ã¿ãã³ã®åå€çæ³ãªã©ãè¡ãããŸãã
M-CAVI ã¯ãCarboGem ã«æ¯ã¹ãŠå ãã«å¯äœçšãå€ããããCarboGem ãæšå¥šããã
ããšãå€ãã§ãã
å»åž«ã¯ååŠçæ³ã®ãµã€ã¯ã«æ¯ã«è容æ§ãè©äŸ¡ãã2ã3 ãµã€ã¯ã«çœ®ãã«èšºææãšåæ§ã®ç»
åæ€æ»ã§æ²»çåå¿æ§ãè©äŸ¡ããŸãã
å šèº«ååŠçæ³åŸã®æè¡çæ³*ã»æŸå°ç·çæ³*
ååŠçæ³åŸã®èè±å šæè¡ã»ãªã³ãç¯å»æž è¡*ãããã¯æŸå°ç·çæ³ã¯ãå±æé²è¡æ§ã®éãã
ãæ£è ããã«èæ ®ãããããšããããŸãã
æŸå°ç·çæ³*
æŸå°ç·çæ³ã¯åºè¡ãçŒçã®ç·©åã«æçšãªããšããããŸãã
åçºãžã®æ²»ç
é é転移ã«å¯ŸããŠãã©ããç³»ãããŒã¹ãšããååŠçæ³ãæœè¡åŸãè «çã®åçºãèªã
ãéã«ã¯ããã³ãã«ãã³*çæ³ãšæ¯æçæ³ãæšå¥šãããŸãããã³ãã«ãã³ã¯ãäžæ¬¡å
åŠçæ³åŸã12 ãæ以å ã«è «çã®é²è¡ãèªããéã«äºæ¬¡ååŠçæ³ãšããŠèæ ®ãããè¬
ã§ããåçºäŸã§ã¯ãã¿ããµã³*ç³»æçå€ãããŒã¹ãšããååŠçæ³ãæ²»éšãžã®åå ãªã©
ãèæ ®ãããŸããäžæ¬¡ååŠçæ³åŸ 12 ãæ以äžçµéããŠããåçºãèªããå Žåã¯ã
ãã©ããç³»ãããŒã¹ãšããäžæ¬¡ååŠçæ³ã®åæœè¡ãæ€èšãããŸãã
è «çã«ããå䜵çãžã®æ²»ç
å°¿è·¯ã®éå¡
èè±çãå°¿ã®æµããæ¢ããŠãè èã«å°¿ãæºãŸãããšããããŸããããã¯çã¿ãšè æ©èœé害ã®
åå ãšãªããŸããçã®é²è¡äŸãæ£è ããã®å šèº«ç¶æ ãæªãå Žåãªã©ã§èè±å šæè¡*ãäžå¯èœ
ãªå Žåã¯ãå°¿è·¯ãèè±ããåãé¢ããŠãäœã®å€ãžäœãçŽãåŠçœ®ãè¡ãããããšããããŸãã
ãã®åŠçœ®ã§ã¯ãè èãããã¯å°¿ç®¡*ãšè ¹éšã®ç®èãšãã€ãªããŸããããããè ç»ïŒããã
ãïŒã尿管ç®èç»ïŒã«ããããã²ãµããïŒãšåŒã°ããŸããå°¿ã¯çå°¿ããã¯ãç®èã«æ¥çãã
ãã©ã¹ããã¯ããã°ïŒããŠãïŒã«æºããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 19
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
æ²»çåŸã®å¯äœçšã®å¯èœæ§ãšããŠäœãããã®ïŒ
æè¡
äžè¬çãªãªã¹ã¯ãšå¯äœçš
ããã€ãã®ãªã¹ã¯ã¯ãå šèº«éº»é *äžã§è¡ãããããããå€ç§çæè¡ãšå ±éããŠããŸãããã
ãã®å䜵çã¯ãŸãã§ãããéèå è¡æ 圢æã埪ç°åšç³»ãåŒåžåšç³»ã®åé¡ãåºè¡ãææããã
ãã¯éº»é *ãžã®åå¿ãªã©ãèµ·ããããŸãããããã®å€ãã¯ãè¡åæ€æ»ã«ããäºé²ããããšã
ã§ããŸãã
èè±ã¯å±æãªã³ãç¯*ãå€§è žã®äžéšã倧è¡ç®¡ããããŠå¥³æ§çæ®åšå®*ãšãšãã«éªšç€å ã«äœçœ®ã
ãŠããŸããæ²»çå¹æãåŸãããã«å¿ èŠãªå€ç§çåé€ã®ç¯å²ã«ãã£ãŠã¯ããããã®çµç¹ã®ãã
ã€ãã¯å·å®³ãåãããããããŸãããæ£ç¢ºãªè¡åã¹ããŒãž*蚺æãç»åæ€æ»ã«ããããã®ã
ããªãªã¹ã¯ãæå°éã«ããããããšãã§ããŸãã
骚ç€éšãè ¹éšã®ãªã³ãç¯*ãéæž ããéã®ãªã³ã管*ã®å·å®³ãé®æã«ãã£ãŠãäžè¢ã«ãªã³ã液
*ãèç©ãæµ®è «ãããããªã³ãæµ®è «*ãçããå¯èœæ§ããããŸããããã¯æè¡ã®çŽåŸãããã
ã¯æ©æã«èµ·ããå¯èœæ§ããããŸãã
èè±å šæåŸã®èè±æ©èœæ¶å€±
èè±å šæãè¡ãããšã«ãããèè±æ©èœã¯å€±ãããŸããå°¿è·¯ãå€æŽããäœã®å åŽãããã¯å€åŽ
ã«å°¿ãéããããã®ãããã€ãã®å€ç§çæè¡æ³ããããŸããã©ã®æ¹æ³ãéžæããã®ãã«ã€ã
ãŠã¯æ³šææ·±ãè©äŸ¡ããå¿ èŠããããè «çã®ã¹ããŒãžãè¡ãããæè¡æ³ãæ£è ããã®å šèº«ç¶æ
ãæ£è ããã®è¶£åã«åºã¥ããŠå€æãããŸããæ§ã ãªæ¹æ³ã«ã€ããŠä»¥äžç°¡åã«æ瀺ããŸããæŽ
ãªãæ å ±ã«é¢ããŠã¯äž»æ²»å»ã«ããããŠããã ãããšãããããããŸãã
åææ§æ°èè±ã æ°ããèè±èåšïŒæ°èè±ãšåŒã°ããŸãïŒãé ãæ¹æ³ã§ããè žç®¡ãçšãããŠ
ããäœæãã尿管*ãšå°¿é*ã®éã«ç眮ããŸããåææ§ãšã¯ãæ°ããèè±ãå ã®èè±ãšåãå Ž
æã«ããããšãæå³ããŸãããã®ããŠãã¯å°¿ã貯ããããšãã§ãããããŠå°¿ã¯å°¿éãéããŠ
æåºããããšãã§ããŸãã
è ¹éšå°¿è·¯å€æŽã è ¹å£ã®äººå·¥ã®éå£éšïŒã¹ããŒãïŒ*ã«å°¿ç®¡*ãã€ãªããæ¹æ³ã§ããããã¯çŽ
æ¥å°¿ç®¡ãã€ãªããããšãããããããã¯ã¹ããŒãã«å°¿ãå°ãããã«å°è žãçšããããšããã
ãŸããå°¿ã¯ãç®èã«æ¥çãããå°ããªãã©ã¹ããã¯è¢ïŒããŠãïŒã«è²¯ããããŸãããŸããäœ
å ã«ããŠããäœæãããã®å°¿ãäœå€ã«èªç¶æµåºããªããããªã¹ããŒããäœæããæ¹æ³ããã
ãŸãããã®å ŽåãããŠãã«äœå€ããã«ããŒãã«*ãæ¿å ¥ããããšã«ããã空ã«ããããšãã§
ããŸããããã¯å°¿çŠå¶åå°¿è·¯å€æŽ*ãšåŒã°ããŸãã
çŽè ž S ç¶éšå°¿è·¯å€æŽã çŽè ž S ç¶éšãšåŒã°ããå€§è žã®æ端éšåã«å°¿ç®¡*ãé£çµãããæ¹æ³ã§
ããçŽè ž S ç¶éšã¯éåžžã䟿ãä¿æããŠããŸãããå°¿ã«å¯ŸããŠãåããããªæ©èœãæã¡ãŸãã
尿管ãšçŽè ž S ç¶éšã®éã«å°è žã®äžéšãé 眮ããæ¹æ³ããããŸãã
å°¿è·¯å€æŽã®å¯äœçš*ãé »åºŠã¯ãå°¿è·¯å€æŽ*ã®ã¿ã€ãã«ãããŸããæãé »åºŠã®é«ãå䜵çã¯ã¹ã
ãŒã*éšã®å°¿ç®¡ãçããªãããšãšãè èã®ææã§ãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 20
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
æ§æ©èœé害ãçæ®æ©èœ*æ¶å€±
ç·æ§ã«ãããæ ¹æ²»çèè±å šæè¡ã§ã¯å°¿é*ã粟å¢*ãåç«è º*ã®æåºãè¡ãããŸãã女æ§ã«ã
ããŠã¯åå®®*ãè£*ã®äžéšã®æåºãè¡ãããŸãããããã®çæ®åšå®*ãæåºããããšã«ããã
æ§æ©èœé害*ãåäŸãäœãèœåã®æ¶å€±ã女æ§ã«ãããŠã¯åäŸãç£ãèœåã倱ããŸãããã®ã
ããªæ£è ããã«å¯ŸããŠãå»åž«ã¯å°éã®ãµããŒãæäŸè ã玹ä»ããããšãã§ããŸãã
æŸå°ç·æ²»ç*
æŸå°ç·æ²»çã®å¯äœçš*ã¯çŽæ¥æšçã«ããŠããèåšã®ã¿ãªãããX ç·*ç §å°ã«ãã£ãŠé¿ããããš
ãã§ããªããèè±è¿ãã®å¥åžžéšã®èåšã«ãçããããšããããŸããèè±çã«å¯Ÿããè¿å¹Žã®æŸ
å°ç·æè¡ã¯ãšãŠãå®å šã§ãé節ãªå䜵ççºçç㯠5%æªæºã§ãã尿路系ãžã®åœ±é¿ãšããŠã¯æ
å°¿æã®çã¿ãå°¿æåè¿«æãè¡å°¿ãæå°¿é絶ãèè±å å£ã®æœ°ç圢æããããŸããè žç®¡äžéšãžã®
圱é¿ã«ã¯äžå¿«æãäžç¢ãç²è¡äŸ¿ãããŸãã§ããè žç©¿åãããããŸãã
女æ§ã«ãããŠã¯ãè£ãçããªãããšã骚ç€éšã®æŸå°ç·æ²»çã§èããããé çºæ§åœ±é¿ã®äžã€ã§
ãã
çæ²»çå»ã¯ãããã®åå¿ãæ倧éã«äºé²ããåãããæ¹æ³ã«ã€ããŠå©èšããŠãããŸãã®ã§ã
ãèããŠãããŸãããã
èè±å æ³šå ¥*çæ³
èè±å BCG*æ³šå ¥ã®äž»ãªå¯äœçšã¯èè±ç*ãšåŒã°ããèè±ã®ççã§ããæãé節ãªå¯äœçšã¯
èè±å£ãã现èãåžåãããè¡ç®¡ã«å ¥ã蟌ãã çµæèµ·ããããå šèº«ææã§ããåŸã£ãŠæ¬æ²»ç
ã¯å ç«æ©èœ*ãäœäžããŠããæ£è ããã«ã¯é©å¿ãšãªããŸãããäžè¬çã«èè±å BCG æ²»çã®
å¯äœçšã¯å¯ŸåŠå¯èœã§ãã
ãã€ããã€ã·ã³ C*ã®ãããªååŠçæ³ã®èè±å æ³šå ¥ã¯èè±ç*ãã¢ã¬ã«ã®ãŒãç®èåå¿ã®ãã
ãªããã€ãã®å¯äœçšãçãããããããŸããã
ååŠçæ³*
ååŠçæ³ã®å¯äœçš*ã¯ãã°ãã°èµ·ãããŸãããè¿å¹Žã¯é©åãªå¯ŸåŠçæ³ã§ããã³ã³ãããŒã«ã§
ããããã«ãªã£ãŠããŸããå¯äœçšã¯æäžããè¬å€ãæäžéãåã ã®æ£è ããã«ç¹ç°çãªçŽ å
ã«ããããŸããããæ£è ãããéå»ã«ä»ã®çŸæ£ã®æ¢åŸãããå Žåã«ã¯ãããã«å¿ããŠããã€
ãã®äºé²åŠçœ®ããšãããããæ²»çã®å€æŽãèæ ®ãããã¹ãã§ããå¯äœçšã¯çŽæ¥èè±ãžå±ææ
äžããïŒèè±å *è¬ç©æ²»çåç §ïŒããããå šèº«çã«ïŒéåžžãçµéèçã«ïŒæäžãããéã«ã
ãéãåºãŸãã
以äžã®ãªã¹ãã¯èè±çã«å¯ŸããŠæè¿çšããããååŠçæ³è¬å€ã§èµ·ããããšãç¥ãããŠããå¯
äœçšã§ããå¯äœçšã®æ§è³ªãé »åºŠãéç床ã¯çšããçµã¿åããããšã«æ§ã ã§ãã
æãé »åºŠã®é«ãå¯äœçšã¯:
è±æ¯ãããã¯æ¯ãèããªã
貧è¡*ãåºè¡ãæã¡èº«ãææãçããå¯èœæ§ã®ããè¡çæ°ã®æžå°
ç²åŽæ
ãããããããã¯é£å·æ°å³
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 21
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
èè±çã«å¯ŸããŠçšããã²ãšã€ãããã¯ãã以äžã®ååŠçæ³è¬å€ã§ãã°ãã°èµ·ããããä»ã®å¯
äœçšã¯:
å£å çãããã¯æœ°ç
å³èŠå€å
äžç¢
ç®ã®ç°ç©æãæ¶ç®
æ¥å éæç
è é害
èŽèŠé害
ååŠçæ³ãåããçæ£è ããã®åå®®ã®èå ã«å¯Ÿããå·å®³
äžåŠç
äžæçãªç¡æçµ
æã«çããå¯äœçšã¯:
èæ©èœã®å€å
å¿çãžã®å·å®³
ææã足æã®ãã³ããã²ãã²ãïŒæ«æ¢¢ç¥çµé害ïŒ
䟿ç§
ããã¿ç®
çºç¹ãããã¯ç®èã®çºèµ€
å³ãããã¯æ¯åã
èèã®å€å
ç®è/çªã®è²ã®å€å
ã¢ã¬ã«ã®ãŒåå¿
ç¹æ»Ž/泚å°éšäœåšå²ã®çç
çºç±ãšæªå¯
çšãªå¯äœçšã¯:
ãã€
ãã ãç®
é ç
å¿æäžæ
ããŸã
é«è¡å§
æåŸã«ãããã€ãã®ååŠçæ³è¬å€ã¯æ¯ä¹³ã«å«ãŸããå¯èœæ§ããããããèµ€ã¡ããã«ã¯æ害ãš
ãªãå¯èœæ§ãããããšã¯æ³šæããã¹ãç¹ã§ãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 22
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
æ²»çåŸã«ã©ããªããšãèµ·ãåŸãã®ãïŒ
çæ£è ããã«ãšã£ãŠæ²»çãå®äºããåŸã«æ²»çã«é¢é£ããçç¶ãçµéšã
ãããšã¯ãŸãã§ã¯ãããŸããã
æ£è ããã¯äžå®ãäžç ãããã¯ãã€ãšãªãã粟ç¥çæ¯æŽãå¿ èŠ
ãšãããããããŸããã
æ²»çäžãããã¯æ²»çåŸãé£æ¬²äœäžãåãæ°ãå šèº«åŠæ æã«äŒŽãã
æ é€ç¶æ ã«åé¡ãçãããããããŸããã
éäžåäœäžãèšæ¶é害ã¯ãå šèº«ååŠçæ³ïŒéèãããã¯çµå£æ
äžïŒã®éã«çããå¯äœçšãšããŠãŸãã§ã¯ãããŸããã
å»åž«ãšã®ãã©ããŒã¢ãã*
æ²»çãå®äºããåŸã®ãã©ããŒã¢ããã«ã¯ã以äžã®ç®çããããŸã:
æ²»çã®å¯äœçšãçºèŠãäºé²ã
åçº*ã®æ©æçºèŠããé©åãªæ²»çã®æ瀺ã
å»åŠæ å ±ã粟ç¥çæ¯æŽãéåžžã®æ¥åžžç掻ãžã®åŸ©åž°ãæå©ãããããã«å¿ èŠãªå°éç
ãªãµããŒãæäŸè ãžã®ç §äŒã
ãã©ããŒã¢ããã®å 容ã«ã¯å®æçãªå€æ¥å蚺ãšæ€æ»ãå«ãŸããŸãããã®å 容ã¯èè±çã®æªæ§
床ïŒã°ã¬ãŒãïŒ*ãã¹ããŒãž*ãè¡ãããæ²»çã®çš®é¡ã«ãããŸããäžè¬çã«ãã©ããŒã¢ããã§
ã¯ã以äžã®æ€æ»ãè¡ããŸã:
ååæçµæ¥é¢æããã®ãå šèº«ã®èº«äœçå¥åº·ãèè±çé¢é£çç¶ã«é¢ããç æŽ
åçº*ãèŠã€ããããããæ°èŠç å€ã®çæ€ãè¡ãããã®èè±é¡æ€æ»*
äžéšå°¿è·¯ç³»ã®ç»åæ€æ»
尿现è蚺*ïŒåçºã®å¯èœæ§ã®ããèè±è «çããã¯ããèœã¡ã现èã®æç¡ã調ã¹ããã
ã®å°¿æ€æ»
è¡æ¶²æ€æ»ïŒè¡æ¶²çååŠæ€æ»ãè æ©èœ
æåã®æ€æ»ã§ç°åžžæèŠã瀺ããå Žåã¯å床ã®æŸå°ç·æ€æ»*
äžè¬çã«åãå ¥ããããŠãããã©ããŒã¢ããã®ãããã³ãŒã«ã¯ãããŸããã次ã®èšèŒã¯æšå¥š
ãããããã©ããŒã¢ããã¹ã±ãžã¥ãŒã«ã§ã:
çå±€é浞最æ§èè±çã«å¯ŸããŠã¯åçºã®ãªã¹ã¯ãããšã«æåã® 2 幎é㯠3-6 ã¶æããšã«ãã
ã®åŸã¯ 6-12ã¶æããšã«ãå®æçãªèè±é¡æ€æ»ãšå°¿çŽ°è蚺ã
ç局浞最æ§èè±çã®æ ¹æ²»æ²»çã§ããæ ¹æ²»çèè±å šæé€è¡åŸã¯å°¿çŽ°è蚺ãèæ©èœãè æ©èœæ€æ»
㯠2 幎é 3-6ã¶æããšã«ããã®åŸã¯èšåºçå€æã«åºã¥ãæœè¡ãããã¹ãã§ããèžéšãäžéš
å°¿è·¯ãè ¹éšã骚ç€éšã®ç»åæ€æ»ã¯åçºã®ãªã¹ã¯ã«åºã¥ã㊠2幎é㯠3-6ã¶æããšã«ããã®
åŸã¯èšåºçå€æã«åºã¥ãæœè¡ãããã¹ãã§ãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 23
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
èåšæž©åæ²»çãæœè¡ãããç局浞最æ§èè±çæ£è ããã«å¯ŸããŠã¯ãå°å ¥ååŠæŸå°ç·æ²»çã«å¯Ÿ
ããå¹æãè©äŸ¡ããå¿ èŠããããŸãããã®åŸãæ ¹æ²»çèè±å šæé€è¡ãåããæ£è ãããšåæ§
ã®ãã©ããŒã¢ããã¹ã±ãžã¥ãŒã«ãæšå¥šãããŸãããã ã 2 幎éã® 3-6ã¶ææ¯ã®èè±é¡æ€æ»
ãšå°¿çŽ°è蚺ããã«ã©ã³ãã çæ€ãå¿ èŠã§ãããã©ããŒã¢ããã®éãæ©æå¯äœçšã 2 次æ§çº
çã«ã€ããŠã¢ãã¿ãªã³ã°ãç¶ç¶ããå¿ èŠããããŸãã
æ£åžžãªç掻ãžã®åŸ©åž°
çããŸãçºçããããšãèãããšãæ¥åžžç掻ãžã®åŸ©åž°ãé£ããæãããããããŸãããèè±
çã«å¯ŸããŠç¥ãããŠããããã€ãã®ãªã¹ã¯å å*ãé€å€ããã¢ããã€ã¹ãå¿ èŠã§ãã
ãã©ããŒã¢ãã*å蚺ããããšã«ãããæ£è ããã¯å»åŠçæ å ±ã粟ç¥çæ¯æŽãå°éçãªãµã
ãŒãæäŸè ãžã®ç §äŒãåããããšãã§ããŸããå°éçãªç²Ÿç¥çã¢ããã€ã¹ã¯ææ矩ã§ããã
ããã«æ£è ããã¯æ£è å£äœãæ£è ããåãã®æ å ±åªäœã«ããæ¯æŽãèŠã€ããããšãã§ããã§
ããããæ é€å£«ã¯é©åãªæ é€æåã«é¢ããŠã¢ããã€ã¹ãæäŸããã§ãããããœãŒã·ã£ã«ã¯ãŒ
ã«ãŒã¯å¹æçãªãªãããªãæäŸããŠããããããªæœèšãèŠã€ããæå©ããããŠããã§ãããã
çãåèµ·ãããã©ããªãã®ã§ãããã?
çãå床çºçããå Žåãããã¯åçº*ãšåŒã°ããŸããåçºã®åºããå ·åã«ããæ²»çæ¹éã¯æ±º
å®ããŸããããã®æ²»çæ¹éã¯ãã®ãã®æ£è ããããšã«æ³šææ·±ã決ããããã¹ãã§ãã
èåšæž©åçæ³*ã§æ²»çãããæ£è ããã«ãããŠã¯ãæ®åè «çã¯åã¹ããŒãžã³ã°ã®éã« 20%ã®
çäŸã«èŠã€ãããŸããããã«æåã«å®å šãªæ²»çå¹æãåŸãæ£è ããã® 20-30%ã«ãããŠã
æž©åããèè±ã«æ°ããªãããã¯åçºã®ç å€ãèµ·ããããŸããæ倧 70%ã®æ£è ããã§ã¯æå
ã®èè±é¡æ€æ»*ã§ã®åŠçœ®åŸãçã®åçºãèªããŸãããããã 1/4 ã®çäŸã§ã¯åŸã«ãªã£ãŠè¿œå
ã®æ²»çïŒå¯èœã§ããã°å šæïŒãå¿ èŠãšããæ°ããªç å€ãåºçŸããŸãã
1 次治çã®ãã©ããç³»ãå«ãã¬ãžã¡ã³ãå®äºããåŸã«é²è¡*ãèªãã転移*æ§ç å€ãæã£ãæ£
è ããã«å¯ŸããŠã¯ããã³ãã«ãã³*ã«ãã 2 次ååŠçæ³ãæšå¥šãããŠããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 24
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
çšèªã®èª¬æ
BCGïŒããŒã·ãŒãžãŒ ïŒBacillus Calmette GuerinïŒ
çŸç ãçããªããã匱æ¯åãããŠã·åçµæ žè(ããŒã·ãŒãžãŒ)ã®ããšãããŒã·ãŒãžãŒã¯èè±ç
ã®æ²»çã«ãããŠå ç«ã·ã¹ãã ãåºæ¿ããããã«æº¶æ¶²ã§çšããããŸãããŸãçµæ ž*ãäºé²ãã
ã¯ã¯ãã³ãšããŠã䜿çšãããŸãã
CT ã¹ãã£ã³ïŒã³ã³ãã¥ãŒã¿ãŒæå±€æ®åœ±
èåšã X ç·*ã§ã¹ãã£ã³ããã®çµæãã³ã³ãã¥ãŒã¿ãŒã§åŠçããèåšã®ç»åãæ§æãã X ç·
*æ®åœ±ã
MRIïŒç£æ°å ±é³Žç»å蚺æ
å»çã§çšããããç»å蚺ææè¡ãç£æ°å ±é³Žãå©çšããŠããŸãããã°ãã°ãç°ãªã现èéã®ã³
ã³ãã©ã¹ããéç«ãããŠæ§é ãããé®®æã«ããããã«ãé 圱å€ã泚å°ãããŸãã
X ç·
X ç·ã¯ãç©äœã®å é¢ã®ç»åãæ®åœ±ããéã«çšããããæŸå°ç·ã®äžçš®ãå»çç®çã§ã¯ãX ç·ã¯
äœã®å éšã®ç»åãåŸãããã«ãäžè¬çã«çšããããŠããŸãã
æªæ§åºŠ
ãã现èã«é¢ããé¡åŸ®é¡èŠ³å¯æèŠã®ç°åžžãšãå¢æ®ããã³è»¢ç§»é床ã®äºæž¬ã«åºã¥ããè «çã«ã€
ããŠã®è¡šçŸãæªæ§åºŠã®è©äŸ¡æ³ã¯ããã®ã¿ã€ãã«ããç°ãªããŸãã
ã¢ãžã¥ãã³ããè£å©ååŠçæ³
ããã«ãããè£å©çæ³ãšã¯ãããæ²»çã®æçµç®æšãéæããããã®æå©ãããããã®æ²»çå¹
æã匷åããæ²»çã§ããããšãã°ãæŸå°ç·ååŠçæ³ãååŠçæ³*ããããæ ¹çµ¶ãããšããç®
æšãéæããããã«æè¡ã®æå©ããããŸããè «çåŠçã«ç°ãªã£ãæ©åºã«ãããŠãæåã«å¯Ÿã
ãå ç«æ©èœã®å¿çã掻æ§åããã¯ã¯ãã³ãå ããè¬å€ãè£å©çæ³ãšãªãããŸãã
移è¡äžç®
å€å±€åãã现èãå«ãã çµç¹ããããã®çŽ°èã¯çž®ãã ã䌞ã³ããããããšãã§ãããããè¡š
é¢ã®çŽ°èã®åœ¢ç¶ãçµç¹ã®äŒžå±ã®çšåºŠã«ããå€åããããšãã§ããã
移è¡äžç®ç
èè±ã尿管*ããããã¯è ç*(å°¿ãéããä¿æããæåºããè èã®äžéšå)ã®å å£ã®ç§»è¡äžç®
现èããçºçããçã移è¡äžç®çŽ°èã¯çµåãããŸãŸåœ¢ç¶ãå€ãããã䌞ã³ããããããšãã§
ããŸãã
éºäŒæ§æ¬ æéºäŒå
芪ããåã«åŒãç¶ãããç°åžžãªããããã¯å€ç°ããéºäŒåã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 25
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
ãšãã«ãã·ã³
ãªã³ãç¯*転移ã䌎ãæ©æã®ä¹³çã®æ²»çè¬ãšããŠä»å€ãšäœµçšããŠäœ¿çšãããè¬å€ã§ãããã®
ä»ã®çãžã®æ²»çã«ãæ€èšãããŠããŸãããšãã«ãã·ã³ã¯ã¢ã³ãã©ãµã€ã¯ãªã³ç³»æè «çæ§æç
ç©è³ªã§ãããšã¬ã³ã¹ããšãã«ãã·ã³å¡©é žå¡©ãšãåŒã°ããŸãã
ã«ããŒãã«
äœå ã«æ¿å ¥ã§ãããã¥ãŒãã液äœãã¬ã¹ãäœã®å€ã«åºãããããããã¯æ³šå ¥ãããªã©ããã
ããªäœ¿çšæ³ããããŸãã
ã«ã«ããã©ãã³
æªæ²»çã®é²è¡ããåµå·£ããã«å¯Ÿããæ²»çãªãã³ã«ä»ã®æããå€ã«ããæ²»çåŸã«åçºããåµå·£
ããã®çç¶ã«å¯Ÿããæ²»çã«çšããããè¬ç©ããŸããé²è¡æãããã¯è»¢ç§»*ãŸãã¯åçº*ãèµ·ã
ããéå°çŽ°èèºããã«å¯Ÿããæ²»çè¬ãšããŠä»ã®æããå€ãšäœµçšãããããšãããããã®ä»ã®
ããã«å¯Ÿããæ²»çè¬ãšããŠãç 究ãããŠããŸããã«ã«ããã©ãã³*ã¯æããå€ã·ã¹ãã©ãã³*
ã«é¡äŒŒããè¬ç©ã§ãã䜿çšæã®å¯äœçšã¯æ¯èŒçå°ãªãã§ãã现èå ã® DNA ã«çµåããæ§è³ª
ãããããã现èã殺å·ããŸãããã©ããååç©ã®äžçš®ã§ãããã©ãã©ãã³ãšãåŒã°ããŸãã
ååŠçæ³ïŒååŠçæ³ã®
è¬å€ã«ããç现èãæ»æ» ãããè «çã®å¢æ®ãæå¶ããçæ²»çã®äžçš®ã§ãããããã®è¬å€ã¯é
åžžãæ£è ããã®éèå ãžç·©åŸã«æ³šå ¥ãããŸãããçã®å±åšã«ãã£ãŠãçŽæ¥ãæ足ã§ãã£ããã
ãšãã«ã¯èèã§ãã£ãããçµå£æäžãã§ãããã®ããããŸãã
é¡ç²çã³ãããŒåºæ¿å åïŒG-CSF ïŒGranulocyte-Colony Stimulating FactorïŒ
奜äžçïŒçœè¡ç现èã®ã²ãšã€ïŒã®ç£çãä¿é²ããæé·å åããµã€ãã«ã€ã³ã®äžçš®ã§ãé è¡
ïŒè¡æ¶²åœ¢æïŒå€ã®ã²ãšã€ããã£ã«ã°ã©ã¹ãã ããžãŒã·ãŒãšã¹ãšããšåŒã°ããŸãã
çŠå¿
æ£è ãããžæ瀺ãããæ²»çãåŠçœ®ãè¡ããªãç¶æ ãçç¶ãçŠå¿ã«ã¯çµ¶å¯ŸççŠå¿ãšçžå¯ŸççŠå¿
ãããã絶察ççŠå¿ã¯ãã®ãããªç¶æ ãçç¶ãæããæ£è ã«ãã®æ²»çã決ããŠããã¹ãã§ãª
ããšããããšãæå³ããŠãããçžå¯ŸççŠå¿ã¯ãã®ãããªç¶æ ãçç¶ãæããäœäººãã®æ£è ã
ãã«å¯Ÿããå©çãå±éºã«åããšããããšãæå³ããŠããŸãã
çµå°¿éçèè±è «çåé€è¡ (TURBT)
å°¿éããæ¿å ¥ãããèè±é¡*ãçšããŠè¡ãããæè¡ãèè±ç蚺æã®ããããèè±å è ã«äžæ£
ã«å¢æ®ããçµç¹ãïŒè «çãé浞最æ§ã§æµ ãå Žåã«ã¯ïŒåé€ããããã«è¡ãããŸããåé€ãã
ãæ€äœã¯èšºæã®ããã«ç ççµç¹æ€æ»ã«éãããŸãã
çµæ ž
é£æ²«ææã«ãŠãããããããžãšäŒæããç¹æ®ãªçš®é¡ã®çŽ°èã«ãã£ãŠçããçŸæ£ã§ããçµæ žè
ã¯äœã®å€ãã®éšåã«ææããå¯èœæ§ããããŸããããã®ã»ãšãã©ã¯èºã«ææããŸããäœå¹Žé
ãçç¶ãåããªãããšããããŸãããç³å°¿ç *ããšã€ãºãããã¯çã®ããã«å®¿äž»ã®äœèª¿ãæª
ããªã£ãæã«çºçããããšããããŸããçµæ žã¯éåžžæçå€ã§æ²»çãå®æ²»ããããšãã§ããŸãã
TB ãšãåŒã°ããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 26
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
é¡åŸ®é¡ç浞最
é¡åŸ®é¡äžã§ã®ã¿ç¢ºèªããããšãã§ããé£æ¥ããçµç¹ãžã®çã®åºããã
ã²ã ã·ã¿ãã³
é²è¡æ§ãããã¯è»¢ç§»æ§èµèçãæ²»çããç®çã§çšããããè¬å€ã®æŽ»æ§æåãå€å€ãšãšãã«è»¢
移æ§ä¹³çãé²è¡æ§åµå·£çãé²è¡æ§ãããã¯è»¢ç§»æ§éå°çŽ°èèºçãæ²»çããç®çã§äœ¿çšããã
ããšããããŸãããã®ä»ã®ççš®ã®æ²»çã«ãããŠãç 究ãããŠããŸããã²ã ã·ã¿ãã³ã¯çŽ°èã®
DNAåæãé»å®³ããç现èã殺å·ããŸãã代è¬æ®æå€ã®ã²ãšã€ã§ãã
åºæå±€
åºæå±€ã¯äžç®ã®çŽäžã«ååšããçæ§çµåçµç¹ãããªãèãå±€ã§ãäžç®ãšãšãã«ç²è*ãæ§æ
ããŠããŸããç²èãšããçšèªã¯åžžã«äžç®ãšåºæå±€ããŸãšãããã®ãæããŸãã
åçº
éåžžã¯ããããçŸæ£ãèªããªããæ€åºã§ããªãæéããã°ããç¶ããåŸã«ãåã³çºçããã
ããçŸæ£ïŒéåžžãèªå·±å ç«çŸæ£ïŒã®ããšãåçºã¯ãæåã«çºçããïŒåçºïŒè «çãšåãéšäœ
ã«åçºããå Žåãããã°ãå¥ã®éšäœã«åçºããå ŽåããããŸããåçºãããåçºæ§çŸæ£ãšã
åŒã°ããŸãã
è ç
è èã®äžå€®ã®éšåãå°¿ã¯ããã«éããããè èããèè±ãŸã§ãã€ãªã管ã§ãã尿管ã«æ³šãã
ãŸãã
çæ€
ç çå»ã«ããæ€æ»ã®ããã«çŽ°èãŸãã¯çµç¹ãæ¡åããããšãç çå»ã¯ãã®çµç¹ãé¡åŸ®é¡ã§èª¿
ã¹ããããã®çŽ°èãŸãã¯çµç¹ã«å¯ŸããŠä»ã®æ€æ»ãå®æœãããããŸããçæ€ã®ææã«ã¯æ§ã ãª
çš®é¡ããããŸããæãäžè¬çãªãã®ãšããŠã¯ä»¥äžã®ãã®ããããŸãïŒïŒ1ïŒåéçæ€ãçµç¹
ã®ãµã³ãã«ã ããæ¡åããæ¹æ³ïŒïŒ2ïŒæåºçæ€ãããããçãããé åã®å šäœãæåºãã
æ¹æ³ïŒïŒ3ïŒéçæ€ãçµç¹ãäœæ¶²ã®ãµã³ãã«ãéãçšããŠæ¡åããæ¹æ³ã倪ãéã䜿çšãã
å Žåã¯ãã³ã¢çæ€ãšåŒã°ããã现ãéã䜿çšããå Žåã¯ãç©¿åºåžåŒçæ€ãšåŒã°ããŸãã
çæ®åšå®/çæ®ç³»
åå«ãçç£ã«é¢ããåšå®ã女æ§ã«ãããŠã¯åµå·£ãåµç®¡ãåå®®ãåå®®é éšãè£ãå«ã¿ãç·æ§ã«
ãããŠã¯åç«è ºã粟巣ãé°èãå«ã¿ãŸãã
ã·ã¹ãã©ãã³
æ§ã ãªçã®æ²»çã«çšããããè¬å€ãã·ã¹ãã©ãã³ã«ã¯éå±çœéãå«ãŸããŠããŸããDNA é
害㚠DNA ã®åè£ãé»å®³ããããšã§ç现èãæ»æ» ãããŸããã·ã¹ãã©ãã³ã¯ã¢ã«ãã«åå€ã®
äžçš®ã§ãã ãã©ãããŒã«ãšãåŒã°ããŸãã
éåŠçæ€èš
ç°ãªãå°éåéã®ãšãã¹ããŒãã®å»åž«ãæ£è ããã®ç ç¶ãæ²»çéžæè¢ãåå³ã»æ€èšããæ²»ç
èšç»ã®ã¢ãããŒããããæ²»çã«ãããŠãéåŠçæ€èšã¯è «çå ç§å»ïŒè¬ã«ããããæ²»çãè¡ã
ïŒãè «çå€ç§å»ïŒæè¡ã«ããããæ²»çãè¡ãïŒãæŸå°ç·è «çå»ïŒæŸå°ç·ã«ããããæ²»çãè¡
ãïŒãå«ãŸããŸããè «ççäŸæ€èšäŒãšãåŒã°ããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 27
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
蚺å¯
ç æ°ã®äžè¬çãªå åã調ã¹ã身äœã®æ€æ»ã
(骚)ã·ã³ãæ®åœ±
ç现èã®ååšããéšäœãå«ãã§ãããäœå çµç¹ã®ç»åïŒã¹ãã£ã³ïŒãé ãè£ çœ®ãã·ã³ãæ®åœ±
ã¯çŸæ£ã蚺æãç æå€å®ãç£èŠããããã«çšããããŸãã埮éã®æŸå°èœæŽ»æ§ãæããååŠç©
質(æŸå°æ§æ žè «)ãéèãéããŠæ³šå°ãããããããã¯é£²ã¿èŸŒãŸããŸããç°ãªã£ãæŸå°æ§æ žè «
ãè¡ç®¡ãéããŠç°ãªã£ãåšå®ã«ç§»åããŸããå°ã®äžã«æšªããã£ãŠãç¹å¥ãªã«ã¡ã©ãæèŒãã
æ©æ¢°ã人äœã®äžãåããæŸå°æ§æ žè «ã«ãã£ãŠçºããããæŸå°èœã®ã¿ã€ããæ€ç¥ããŸããã³ã³
ãã¥ãŒã¿ãŒãæŸå°æ§æ žè «ã®å¢å ããŠããéšäœã®ç»åãäœããŸãããããã®éšäœã¯ç现èãå«
ãã§ããå¯èœæ§ããããŸããæŸå°æ§æ žè «èµ°æ»ãšãåŒã°ããŸãã
é²å±
å»çã«ãããŠãçã®ãããªçŸæ£ãæªåãããäœå ã§åºãã£ããããŠããããšã
äžç®
ãäžç®ããšããçšèªã¯ã管è èåšãè ºçµç¹ãèŠãã人äœã®å€è¡šé¢ãæ§æãã现èã®ããšãæ
ããŸããäžç®çŽ°èã¯èåšãä¿è·ãããŸãã¯å ã¿èŸŒã圹å²ãæããããã®å€ãã¯ç²æ¶²ããã®ä»
ã®åæ³ç©ãç£çããŸãã
人工èé
æè¡ã§äœæãããäœã®å åŽéšåããå€åŽãžã®éããç©Žã
æ§æ©èœé害
ååãªæ§äº€ã楜ããããšãäžå¯èœãªç¶æ ãæ§æ¬²ãè奮ããªã«ã¬ãºã ããããŠå埩ãªã©ã®ãã
ã€ãã®æ®µéã§æ§æŽ»åã«åœ±é¿ãäžããå€çš®å€æ§ã®åé¡ãå«ã¿ãŸãã
粟å¢
çŽ 5 ã»ã³ãé·ã®å¯Ÿã«ãªã£ãŠãã管ç¶ã®è ºã§ããã粟管èšå€§éšã«ä»çããŠããŸãã粟å¢ã¯å
ç«è ºã®äžæ¹ã«äœçœ®ããŠããŸãã粟å¢ã®ãã®ãã®ã¯åç«è ºãšé£çµããŠãã管ãæããŠããŸãã
粟å¢ã¯ç²Ÿæ¶²ã«å«ãŸãã液ã®å€§éšåãäœã£ãŠããŸãã
è ºãã
äžéšã®å èã®å åŽãèŠã现èããçºçããããã®ãã¡ãè ºãšé¡äŒŒã®ïŒåæ³æ§ã®ïŒæ§è³ªããã€
ãã®ã
å šèº«éº»é
äžæçã«æèŠãæ¶å€±ãããããšããŸããšãŠãæ·±ãç ãã®ããã«å®å šã«èªèŠãæ¶å€±ãããããšã
ç¹æ®ãªè¬å€ãããã¯éº»é è¬*ãšåŒã°ããå¥ã®ç©è³ªã«ããåŒãèµ·ããããŸããå šèº«éº»é ã¯æè¡
ãä»ã®åŠçœ®ã®éãæ£è ããã®çã¿ãé²ããŸãã
åç«è º
ç·æ§çæ®åšå®*ã®äžã€ã®è ºãåç«è ºã¯èè±ã®çŽäžã§å°¿éïŒèè±ã空ã«ãã管ïŒã®äžéšãåã
å²ãã§ããŸãããŸã粟液ã®äžéšãæ§æãã液äœãç£çããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 28
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
åç«è ºé圢æïŒBPHïŒBenign prostatic hyperplasiaïŒ
åç«è ºçµç¹ãé圢æããããšã«ããå°¿é*ãèè±ãå§è¿«ãããå°¿ã®æµããé®æããŠããè¯æ§
ã®ïŒéçæ§ã®ïŒç æ ãåç«è ºè¥å€§çãšãåŒã°ããŸãã
èåšæž©åæ²»çïŒæè¡
æ©èœãæ§é ãç¶æãããããæ倧éã«äžããããèåšãæ®ãæè¡ãèåšãå®å šã«æåºããæ ¹
æ²»çæè¡ãåããããšãã§ããªãããããã¯æãŸãªãæ£è ãããžæ瀺ãããŸãã
ã¿ããµã³
现èåè£ãæ¢ããããšã«ããã现èã®æé·ãé»å®³ããè¬ã®äžã€ãã¿ããµã³ã¯åŸ®å°ç®¡ïŒæ糞å
è£ã«ãããŠæè²äœã®ç§»åãå©ãã现èå æ§é ç©ïŒã劚害ããŸããããæ²»çã«çšããããŸãã
æ糞åè£é»å®³å€åã³åŸ®å°ç®¡é»å®³è¬ã®äžçš®ã
転移
身äœã®ããå Žæããä»ã®å Žæãžãšãããæ¡ããããšãæ¡ãã£ã现èã«ãã£ãŠåœ¢æãããè «ç
ã¯è»¢ç§»è «çã転移ãšåŒã°ããŸããè»¢ç§»è «çã¯åçºã®è «çãšããªã现èãå«ã¿ãŸãã
é»é¢æŸå°ç·ç §å°
X ç·*è£ çœ®ãæŸå°ç·æ§ç©è³ªãå®å®ç©ºéããå°çã«å ¥ã£ãŠããæŸå°ç·ããã®ä»ã®åå ã«ãã£ãŠ
çããïŒæŸåºãããïŒæŸå°ç·ã®ã²ãšã€ã®åãé«ç·éã§é»é¢æŸå°ç·ç §å°ã¯çŽ°èå ã§ååŠæŽ»æ§ã
å¢å ãããçãå«ãå¥åº·ã«å±éºãçãããå¯èœæ§ããããŸãã
ç³å°¿ç
äœå ã§ååãªã€ã³ã¹ãªã³ãç£çãããªããã€ã³ã¹ãªã³ãé©åã«äœ¿çšãããªãããã«è¡äžã®ã°
ã«ã³ãŒã¹ïŒç³ã®äžçš®ïŒæ¿åºŠãç°åžžã«é«ããªãçŸæ£ãæããŸãã
ãããœã«ãã·ã³
æ§ã ãªçš®é¡ã®ããã®æ²»çã«çšããããèšåºç 究ãè¡ãããŠããè¬ã§ãããããœã«ãã·ã³ã¯
Streptomyces å±ã®çŽ°èããåé¢ãããŸããDNA ãç Žå£ãããã现èãæ»æ» ããããã¢ã³
ãã©ãµã€ã¯ãªã³æè «çæçç©è³ªã®äžçš®ã§ãã
å èã®
èºãå¿èãæ¶ååšç³»ã»ææ³ç³»ã»çæ®ç³»èåšã埪ç°åšãªã©äœå ã®è»éšçµç¹ã§ããå èã®ããšã
èçŒç浞最
èçŒçã«æãããªé£æ¥ããçµç¹ãžã®çã®åºããã
尿现管
æçµçã«å°¿ãšããããã®ãéæ©èœãæãããè èã®çµç¹å ã®å°ããªç®¡ãè èã®åºæ¬çãªæ©èœ
åäœã§ãã糞çäœã®äžéšã§ãã
尿管
è èããèè±ãŸã§å°¿ãéã¶ç®¡ã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 29
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
尿管é¡æ€æ»
尿管é¡ãçšããè èãšå°¿ç®¡*ã®å åŽã®æ€æ»æ³ã尿管é¡ãšã¯å æºãšèŠ³å¯ã®ããã®ã¬ã³ãºãæã
ã现é·ãã管ç¶ã®åšå ·ãçŸæ£ã®æèŠãé¡åŸ®é¡äžã§ç¢ºèªããç®çã§çµç¹ãæ¡åããããã®éå ·
ãšããŠãçšããããŸãã尿管é¡ã¯å°¿éããèè±ã尿管*ãè ç*(å°¿ãéããä¿æããæåºã
ãè èã®äžéšå)ãžæ¿å ¥ãããŸãã
尿现è蚺
ç æ°ãæ€åºããããã«ãå°¿äžã®çŽ°èã調ã¹ãæ€æ»ã
å°¿é
èè±ãäœã®å€åŽã«ã€ãªããŠãã管ãç·æ§ã®å Žåãå°¿éã¯å°¿ãšåæã«ç²Ÿæ¶²ãéã³ãŸãã
å°¿è·¯å€æŽ
å°¿ãäœå€ã«åºãããã®æ°ããçµè·¯ãé ãããã®å€ç§çåŠçœ®ãå€§è žãžå°¿ãæµãæ¹æ³ãèè±ã®å°¿
ãæåºããããã«ã«ããŒãã«ã䜿çšããæ¹æ³ãè ¹å£ã«æåºå£ãäœæãäœå€ã®ããã°ã«å°¿ãé
ããæ¹æ³ãªã©ãå°¿è·¯å€æŽã«å«ãŸããŸãã
å°¿è·¯äžç®
è èã®äžå€®éšåã§ããè çã尿管*ãèè±ãå°¿é*ã®å è ã®äžç®ã
ç²è
ããèåšãäœè ã®æ¹¿æœ€ããå å£ã ç²èã«ããç·ã¯ç²æ¶²ãç£çããŸãã
埮å°è»¢ç§»
åçºè «çããäœã®ä»ã®éšåãžåºãã£ãŠãããã®ã®ãã¹ã¯ãªãŒãã³ã°ãããã¯èšºææ€æ»ã§æ€åº
ãããªãå°æ°ã®ç现èã
ç çå»
é¡åŸ®é¡ã䜿ã£ãŠçŸæ£ã®çŽ°èãçµç¹ãæ€èšããç ççµç¹åŠ*ãå°éãšããå»åž«ã®ããšã
ç ççµç¹åŠ
é¡åŸ®é¡ã䜿ã£ãçµç¹*ããã³çŽ°èã®ç 究ã
ãã³ãã«ãã³
èè±çã®ã»ã«ã³ãã©ã€ã³ã®æ²»çã«å¯Ÿããæçæ²»çã®ã²ãšã€ããã³ã«ã¢ã«ã«ãã€ãç³»ã®æçå€
ã§ãã现èåè£ã®éã现èå éªšæ Œåœ¢æã«éèŠãªãã¥ãŒããªã³ã«çµåããŸããç现èå ã§ãã¥
ãŒããªã³ãšçµåããããšã«ãã£ãŠãã³ãã«ãã³ã¯çŽ°èå éªšæ Œã®åœ¢æãæ¢ããŠã现èåè£ãæ
å¶ããç现èã®å¢æ®ãæ¢ããŸãã
ãã³ãã©ã¹ãã³
é²è¡æ§ããžãã³ãªã³ãè «ãé²è¡æ§ç²Ÿå·£è现èçãªã©ã®çãæ²»çãããããä»ã®è¬å€ãšãšãã«
çšãããã掻æ§åè¬å€ããã®ä»ã®çè «ã®æ²»çã«å¯ŸããŠãç 究ãããŠããŸãããããããœãŠãš
ããæ€ç©ããæœåºãããŸããããã®äœçšæ©åºã¯ã现èåè£ãæ¢ããŠçŽ°èå¢æ®ãæå¶ããããš
ã«ããç现èã殺ããŸãããã³ã«ã¢ã«ã«ãªã€ãç³»ã®è¬å€ã§ãããææ糞åè£è¬ã§ãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 30
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
ãã©ããŒã¢ããïŒçµé芳å¯
æ²»çåŸã®æ£è ããã®å¥åº·ç¶æ ã芳å¯ããããšãèšåºç 究ãèšåºè©Šéšã«åå ãã被éšè ã®ãç
究äžãŸãç 究åŸã«ãããå¥åº·ç¶æ ã®äžå®æéã«æž¡ã远跡ãå«ãŸããŸãã
å¯äœçš
æ²»çãå¥åº·çãªçµç¹ãããã¯åšå®ã«åœ±é¿ãäžããéã«çããåé¡ã®ããšãçæ²»çã«ãããŠã
ãã€ãã®å ±éããå¯äœçšã«ã¯ç²åŽãçŒçãåãæ°ãååãè¡æ¶²çŽ°èæ°ã®æžå°ãè±æ¯ãå£å ç
ãªã©ããããŸãã
æå¹³äžç®çŽ°èãã
äœå ã®ããã®é²å±ãç¹ã«ãããçºçéšäœããäœã®ä»ã®éšäœãžè»¢ç§»ããŠããªããã©ãããšãã
ããšãç¥ãããã«èšºå¯ãæ€æ»ãè¡ãããšãæåã®æ²»çãèšç»ããããã«ãçŸæ£ã®ç æ蚺æã¯
ãšãŠãéèŠã§ãã
æŸå°ç·æ€æ»
蚺æãšæ²»çã®äž¡æ¹ã®ãããäœå ã®èåšãæ§é ãçµç¹ãèŠèŠåããç»åæè¡ïŒX ç·æ®åœ±ãè¶ é³
æ³¢*ãã³ã³ãã¥ãŒã¿æå±€æ®åœ±æ³*ãæ žå»åŠãªã©ïŒãçšããæ€æ»æ³ã
æŸå°ç·æ²»ç
ããã®ç¹å®ã®é åã察象ãšããããæ²»çã«çšããããæŸå°ç·æ²»çã
èè±ç
èè±ã®ççã
èè±é¡æ€æ»
èè±é¡ãå°¿é*ããæ¿å ¥ãèè±ãå°¿éã調ã¹ãæ€æ»ãèè±é¡ãšã¯å æºãšèŠ³å¯ã®ããã®ã¬ã³ãº
ãæãã现é·ãã管ç¶ã®åšå ·ãé¡åŸ®é¡äžã«ç çæèŠã確èªããããã®çµç¹æ¡åã«ãçšããã
ãŸãã
èè±å ïŒæ²»çïŒ
èè±å æ²»çã¯èè±ãžçŽæ¥æ³šå ¥ããŸãã
èè±å æ³šå ¥
ãã£ãããããã¯å°ããã€èè±å ã«æ¶²äœãæ³šå ¥ããããšã
ãã€ããã€ã·ã³C
æè «çæäœãšåŒã°ããè¬å€çŸ€ã«å±ããæçå€ã®äžã€ã
麻é
å¯éçãªæèæ¶å€±ç¶æ ã§ã¯ãæ£è ããã¯çã¿ãæããŸããããéåžžã®åå°ãç¡ããã¹ãã¬ã¹
ãžã®åå¿ãå°ãªããªããŸããããã¯éº»é ãšããŠç¥ãããç©è³ªã®äœ¿çšã«ãã£ãŠãæå³çã«èªå°
ãããŸãã麻é ã¯å®å šã«ããããšãéšåçã«ããããšãåºæ¥ãŸãããŸããæ£è ããã«å¯ŸããŠ
ããããªå€ç§åŠçœ®ãããããšãåºæ¥ãããã«ãªããŸãã
Bladder cancer: a guide for patients - Information based on ESMO Clinical Practice Guidelines - v.2016.1 Page 31
This document is provided by the Anticancer Fund with the permission of ESMO. The information in this document does not replace a medical consultation. It is for personal use only and cannot be modif ied, reproduced or disseminated in any way without written permission from ESMO and the Anticancer Fund.
ã¡ãœãã¬ãã»ãŒã
ããã€ãã®ççš®ãé¢ç¯ãªãŠããã也ç¬ã®ãããªé節ãªç®èç å€ãæ²»çããããã«çšããè¬ã
ã¡ãœãã¬ãã»ãŒãã¯çŽ°èãDNAãåæããããšãæå¶ããç现èã殺å·ããããšãã§ããŸ
ãã代è¬æ®æå€ã®äžã€ã§ããã¢ã¡ããããªã³ããšã ãã£ãšãã¯ã¹ããªã¥ãŒããã¬ãã¯ã¹ãšã
åŒã°ããŠããŸãã
å ç«æ²»ç
çãææããã®ä»ã®çŸæ£ãšæŠãããã«å ç«ã·ã¹ãã ã®æŽ»æ§ãå¢å€§ãããããããã¯å埩ãã
ãæ²»çãããã€ãã®çã®æ²»çã«ãã£ãŠçãããããçšåºŠã®å¯äœçš*ãæžããç®çã§ãçšãã
ããŸããå ç«æ²»çã«çšããããè¬å€ãšããŠã¯ã¢ãã¯ãããŒã«æäœãæé·å åãã¯ã¯ãã³ãã
ããŸãããããã®è¬å€ã¯çŽæ¥çæçå¹æãæããå ŽåããããŸãã修食ç©è³ªçæ³ãçç©åŠç
æ²»çãçç©åŠççæ³ãBRMæ²»çãšãåŒã°ããŸãã
äºåŸ
ãã®çŸæ£ã®ãã©ããšæãããçµæãŸãã¯çµéïŒå埩ã®èŠèŸŒã¿ãŸãã¯åçº*ã®èŠèŸŒã¿ã®ããšã§
ãã
ãªã¹ã¯å åïŒå±éºå åïŒãªã¹ã¯ãã¡ã¯ã¿ãŒ
ç æ°ãé²è¡ãããæ©äŒãå¢å ããããªã«ãã§ããããã®å±éºå åãšããŠäŸãæãããšã幎霢
ã幎霢ãç¹å®ã®ããã®å®¶ææŽãå«ç ç¿æ £ãæŸå°ç·ãŸãã¯ç¹å®ã®ååŠè£œåãžã®æŽé²ãç¹å®ã®ãŠ
ã€ã«ã¹ãŸãã¯çŽ°èãžã®ææããªãã³ã«ç¹å®ã®éºäŒåå€åããããŸãã
è¯æ§
ããã§ã¯ãªãããšãè¯æ§è «çã¯å¢å€§ããããšããããŸãããäœã®ä»ã®éšäœã«æ¡ããããšã¯ã
ããŸãããéæªæ§ãšãåŒã°ããŸãã
ãªã³ãç¯
å ç«æ©æ§ã«ãããŠå¿ èŠäžå¯æ¬ ãªçœè¡çã®äžçš®ã§ãããªã³ãçã«ã¯ T 现èãB 现èãããã¥
ã©ã«ãã©ãŒïŒNKïŒçŽ°èã®å€§ãã 3 ã€ã®çš®é¡ããããå ç«æ©æ§ã«ãããŠç¹ç°çãªåœ¹å²ãæ ã
ãŸãã
ãªã³ãæµ®è «
äœåãªãªã³ã液ãçµç¹ã§å ç©ããèšåŒµããç¶æ ããããªã³ã管ãéå¡ãå·å®³ããããã¯æè¡
ã§é€å»ãããéãè ãäžè¢ã«çããå¯èœæ§ããããŸãã